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A B S T R A C T
Background
Borderline personality disorder (BPD) is a relatively common personality disorder with a major impact on health services as those
affected often present in crisis, often self-harming.
Objectives
To evaluate the effects of psychological interventions for people with borderline personality disorder.
Search strategy
We conducted a systematic search of 26 specialist and general bibliographic databases (December 2002) and searched relevant reference
lists for further trials.
Selection criteria
All relevant clinical randomised controlled trials involving psychological treatments for people with BPD.The definition of psychological
treatments included behavioural, cognitive-behavioural, psychodynamic and psychoanalytic.
Data collection and analysis
We independently selected, quality assessed and data extracted studies. For binary outcomes we calculated a standard estimation of
the risk ratio (RR), its 95% confidence interval (CI), and where possible the number need to help/harm (NNT/H). For continuous
outcomes, endpoint data were preferred to change data. Non-skewed data from valid scales were summated using a weighted mean
difference (WMD).
Main results
We identified seven studies involving 262 people, and five separate comparisons. Comparing dialectical behaviour therapy (DBT) with
treatment as usual studies found no difference for the outcome of still meeting SCID-II criteria for the diagnosis of BPD by six months
(n=28, 1 RCT, RR 0.69 CI 0.35 to 1.38) or admission to hospital in previous three months (n=28, 1 RCT, RR 0.77 CI 0.28 to 2.14).
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Self harm or parasuicide may decrease at 6 to 12 months (n=63, 1 RCT, RR 0.81 CI 0.66 to 0.98, NNT 12 CI 7 to 108). One study
detected statistical difference in favour of people receiving DBT compared with those allocated to treatment as usual for average scores
of suicidal ideation at 6 months (n=20, MD -15.30 CI -25.46 to -5.14). There was no difference for the outcome of leaving the study
early (n=155, 3 RCTs, RR 0.74 CI 0.52 to 1.04). For the outcome of interviewer-assessed alcohol free days, skewed data are reported
and tend to favour DBT. When a substance abuse focused DBT was compared with comprehensive validation therapy plus 12-step
substance misuse programme no clear differences were found for service outcomes (n=23, 1 RCT, RR imprisoned 1.09 CI 0.64 to
1.87) or leaving the study early (n=23, 1 RCT, RR 7.58 CI 0.44 to 132.08). When dialectical behaviour therapy-oriented treatment
is compared with client centred therapy no differences were found for service outcomes (n=24, 1 RCT, RR admitted 0.33 CI 0.08
to 1.33). However, fewer people in the DBT group displayed indicators of parasuicidal behaviour (n=24, RR 0.13 CI 0.02 to 0.85,
NNT 2 CI 2 to 11). There were no differences for outcomes of anxiety and depression (n=24, 1 RCT, RR anxiety BAI >/=10 0.60 CI
0.32 to 1.12; RR depression HDRS >/=10 0.43 CI 0.14 to 1.28) but people who received DBT had less general psychiatric severity
than those in the control (MD BPRS at 6 months -7.41 CI -13.72 to -1.10). Finally this one relevant study reports skewed data for
suicidal ideation with considerably lower scores for people allocated to DBT. When psychoanalytically oriented partial hospitalization
was compared with general psychiatric care the former tended to come off best. People who received treatment in a psychoanalytic
orientated day hospital were less likely to be admitted into inpatient care when measured at different time points (e.g. n=44, RR
admitted to inpatient 24 hour care >18 to 24 months 0.05 CI 0.00 to 0.77, NNT 3 CI 3 to 10) Fewer people in psychoanalytically
oriented partial hospitalization needed day hospital intervention in the 18 months after discharge (n=44, 1 RCT, RR 0.04 CI 0.00 to
0.59, NNT 2 CI 2 to 8). More people in the control group took psychotropic medication by the 30 to 36 month follow-up, than those
receiving psychoanalytic treatment (n=44, 1 RCT, RR 0.44 CI 0.25 to 0.80, NNT 3 CI 2 to 7). Anxiety and depression scores were
generally lower in the psychoanalytically oriented partial hospitalization group (n=44, 1 RCT, RR >/=14 on BDI 0.52 CI 0.34 to 0.80,
NNT 3 CI 3 to 6), as are global severity scores. People receiving psychoanalytic care in a day hospital had better social improvement
in social adjustment using the SAS-SR at 6 to 12 months compared with people in general psychiatric care (MD -0.70 CI -1.08 to -
0.32). Rates of attrition were the same (n=44, 1 RCT, RR leaving the study early 1.00 CI 0.23 to 4.42).
Authors’ conclusions
This review suggests that some of the problems frequently encountered by people with borderline personality disorder may be amenable
to talking/behavioural treatments but all therapies remain experimental and the studies are too few and small to inspire full confidence
in their results. These findings require replication in larger ’real-world’ studies.
P L A I N L A N G U A G E S U M M A R Y
Psychological therapies for people with borderline personality disorder
People with borderline personality disorder, are often anxious, depressed, self-harm, in crisis and are difficult to engage in treatment.
In this review of the talking/behavioural therapies for people with borderline personality disorder, we identified seven studies involving
262 people, over five separate comparisons. Dialectical behaviour therapy (DBT) included treatment components such as prioritising a
hierarchy of target behaviours, telephone coaching, groups skills training, behavioural skill training, contingency management, cognitive
modification, exposure to emotional cues, reflection, empathy and acceptance. DBT seemed to be helpful on a wide range of outcomes,
such as admission to hospital or incarceration in prison, but the small size of included studies limit confidence in their results.
A second therapy, psychoanalytic orientated day hospital therapy, also seemed to decrease admission and use of prescribed medication
and to increase social improvement and social adjustment. Again, this is an experimental treatment with too few data to really allow
anyone to feel too confident of the findings. Even if these are trials undertaken by enthusiasts and difficult to apply to everyday care,
they do suggest that the problems of people with borderline personality disorder may be amenable to treatment. More well-designed
studies are both justifiable and urgently needed.
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B A C K G R O U N D
Borderline personality disorder (BPD) was a condition recognised
in the 19th century as existing in the borderland between psychosis
and neurosis (Stone 1990). Subsequent psychoanalytic contribu-
tions have reaffirmed this distinction emphasising that a persons
sense of identity is weak but nevertheless the capacity to test reality
remains. There are three main clinical components to this disor-
der. First, an unstable sense of self with difficulty in interpersonal
relationships, second, impulsiveness and third, affective instabil-
ity. Some believe that borderline personality disorder is a variant of
affective disorders (Coid 1993). Despite its controversial nature,
BPD is the focus of great interest with more reports and books
appearing on the disorder than any other personality disorder (
Stone 1993). Bipolar personality disorders importance stems from
the significant impact it has on mental health services.
Currently, diagnosis using operational criteria is not straightfor-
ward. The Diagnostic Statistical Manual, version 4 (DSM-IV) (
APA 1994), stipulates that nine criteria cover the above features,
and that for a definite diagnosis five have to be met. Meeting four
of the criteria results in a probable diagnosis. The International
Classification of Diseases, version 10, refers to the condition of
Emotionally Unstable Personality Disorder (F60.3) of which there
is an impulsive type (F60.30) and a borderline type (F60.31) (
ICD-10 1992). The latter essentially overlaps with the DSM-IV
definition. There are special problems in its diagnosis in adoles-
cents and young adults where existential dilemmas may be mistak-
enly be classified as having BPD (DSM-IV). A significant problem
is that with this type of polythetic definition it is possible for two
people to satisfy the criteria and yet have very different personal-
ities. This heterogeneity is a major problem in assessing the im-
pact of an intervention. In summary, despite its importance and
impact on mental health practice, there are major problems in the
definition of BPD; problems that are likely to impact in turn on
assessing the efficacy of treatment interventions.
The prevalence of borderline personality disorder is about 2%
(DSM-IV) in the general population (APA 1994) but it is present
in 20% of in-patients in psychiatric wards (APA 1994). It is a
disorder predominantly diagnosed in women (75%). Common
co-existing problems include mood disorders, substance misuse,
eating disorders and post traumatic stress disorder. BPD is also
associated with other personality disorders and has a high rate of
suicide when associated with mood disorders or alcoholism (Stone
1990 ). The problem of deliberate self-harm is prevalent in this
group (Linehan 1993).
There is compelling evidence that, while the short to medium-
term outcome of BPD is poor (being similar to that of schizophre-
nia) longer term follow-up shows a more favourable course (Stone
1990, Paris 2003, McGlashan 1986, Plakun 1985). These longer-
term studies had almost identical results despite differences in the
intensity of treatment and socio-demographic status. Neverthe-
less, most people still had significant levels of symptoms and dis-
ability (Perry 1993). Nine studies found the average suicide rate
in BPD to be 6% (range 3-9%) (Perry 1993).
The direct costs of BPD are considerable in that many people
so affected make major demands on health professionals. These
demands are often so intense that one professional eventually burns
out with the same cycle being repeated with another (Benjamin
1993). Hence, it has been suggested that a team, rather than an
individual manages, a person with BPD (NIMH(E) 2003).
O B J E C T I V E S
To evaluate the effects of psychological interventions for people
with borderline personality disorder.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included all relevant randomised control trials with or with-
out blinding. We excluded quasi-randomised trials, such as those
where allocation was undertaken on surname. If a trial was de-
scribed as double blind, but it was implied it had been randomised,
these trials would have been included in a sensitivity analysis. If
there had been no substantive differences within primary out-
comes when these ’implied randomisation’ studies were to have
been added and included in the final analysis. However, if there
had been a substantive difference then only clearly randomised
trails were to have been used. Randomised crossover studies were
eligible but only data up to the point of first crossover because of
the instability of the problem behaviours and the likely carryover
effects of all treatments.
Types of participants
Adults (18 years or over) with a diagnosis of borderline personality
disorder, however diagnosed.
We classified formal diagnoses of borderline personality disorder,
made using operational criteria such as described by DSM-IV (
APA 1994), as ’A’ grade diagnoses. Grade A also included formal
diagnoses of borderline personality disorder where criteria other
than DSM had been used but, which nonetheless, had satisfied
three or more DSM criteria.
Finally, we also considered diagnoses where no formal label of
borderline personality disorder had been made on people who
nonetheless satisfied three or more DSM criteria to be ’Grade A’
diagnoses. All others were classified as ’Grade B’ diagnoses.
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We also included personality-disordered people with co-morbid
mental health problems other than the major functional mental
illnesses (i.e. schizophrenia, schizoaffective disorder or bipolar dis-
order) and classified these people into Grade A or B diagnoses
according to the method described above. The decision to ex-
clude people with co-morbid major functional illness was based on
the rationale that the presence of such disorders would confound
whatever other psychopathology (including personality disorder)
might be present.
Diagnostic criteria for DSM-IV Borderline Personality Disorder
are as follows (APA 1994):
- frantic efforts to avoid real or imagined abandonment
- a pattern of unstable and intense interpersonal relationships char-
acterized by alternating between extremes of idealization and de-
valuation identity disturbance
- markedly and persistently unstable self-image or sense of self im-
pulsivity in at least two areas that are potentially self-damaging
(e.g., spending, sex, substance abuse, reckless driving, binge eat-
ing)
- recurrent suicidal behaviour, gestures, or threats, or self-mutilat-
ing behaviour
- affective instability due to a marked reactivity of mood (e.g.
intense episodic dysphoria, irritability, or anxiety usually lasting a
few hours and only rarely more than a few days)
- chronic feelings of emptiness
- inappropriate, intense anger or difficulty controlling anger (e.g.
frequent displays of temper, constant anger, recurrent physical
fights)
- transient, stress-related paranoid ideation or severe disassociative
symptoms
Types of interventions
There are numerous psychologically based therapeutic interven-
tions for people with personality disorder. These vary in both their
theoretical approach and practical application (e.g. group vs. in-
dividual therapy).
The huge number of psychological interventions documented in
the literature makes it almost impossible to prescribe an exhaustive
list of individual therapies to be included in the review. There-
fore we used the following six broad categories to classify treat-
ment interventions: Cognitive Behavioural Therapy (CBT), Be-
havioural Therapy, Psycho-Dynamic Therapy, Group Therapy,
Miscellaneous Therapy and Standard Care.
All therapies and interventions included within the review (irre-
spective of the category they are subsequently assigned to had to
demonstrate the following basic standards to be considered for in-
clusion: a) have a clarity of purpose (i.e. the anticipated therapeu-
tic gains must be pre-defined); b) have a defined rational for par-
ticipant inclusion / exclusion; and c) have a detailed description
of the intervention process (including setting, duration of sessions
and interventions, etc.).Where studies integrate a number of ther-
apeutic approaches the researchers will use the major therapeutic
component to classify the intervention.
1. Cognitive behavioural therapy (CBT)
A variety of interventions have been labelledCBT and it is difficult
to provide a single, unambiguous definition. Recognising this, we
constructed criteria we felt to be both workable and to capture the
elements of good practice in CBT.
In order to be classified as ’well defined’ the intervention must
clearly demonstrate that a component of the intervention: 1) in-
volves the recipient establishing links between their thoughts, feel-
ings and actions with respect to the target symptom; and 2) the
correction of the person’smisperceptions, irrational beliefs and rea-
soning biases related to the target symptom. In addition a further
component of the intervention should involve either or both of
the following: i) the recipient monitoring his or her own thoughts,
feelings and behaviours with respect to the target symptom; and
ii) the promotion of alternative ways of coping with the target
symptom.
All therapies that do not meet these criteria but are labelled ’CBT’
or ’Cognitive Therapy’ will be included as ’less well defined’ CBT.
A sensitivity analysis on the primary outcomes of this review (see
Types of Outcomes) would have been conducted in order to in-
vestigate if this hierarchy of definition makes any difference.
2. Behavioural therapy
We considered any interventions in which the therapist attempts
solely to alter specific behavioural components of problems asso-
ciated with personality disorder in this category.
3. Psychodynamic therapy
In order to be classified as psychodynamic, the intervention must
not focus on a specific presenting problem (such as aggression)
but rather on the unconscious conflicts that repress the individual
and need to be confronted and re-evaluated in the context of
the people’ adult life. The following two components had to be
documented in the therapeutic intervention for the therapy to be
included: a) it must explore an element of the unconscious, and b)
emphasises the importance of the patient’s relational interaction
with the therapist.
4. Group therapy
We would include any intervention that extends beyond the in-
dividual and specifically uses a group format in this category
(e.g. family therapy and psychoanalytic group therapy).We would
have included studies of therapeutic communities in this category,
mindful of the existing systematic review of this specific interven-
tion (Warren 2001).
5. Miscellaneous
We included any psychological interventions that do not fall into
any of the above definitions but that satisfied the general criteria
in this category. Examples may include art and music therapy.
6. Standard care
We defined this as the care a person would normally receive had
they not been included in the research trial. The category ’standard
care’ also incorporates ’waiting list control groups’, where partici-
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pants receive drug or other interventions.
Types of outcome measures
1. Death - Sudden and unexpected death and natural causes
2. Global state
2.1 Relapse*
2.2 Time to relapse
2.3 No clinically important change in global state
2.4 Not any change in global state
2.5 Average endpoint global state score
2.6 Average change in global state scores
3. Behaviour
3.1 General behaviour
3.1.1 No clinically important change in general behaviour
3.1.2 Not any change in general behaviour
3.1.3 Average endpoint general behaviour score
3.1.4 Average change in general behaviour scores
3.1.5 Compulsory administration of treatment**
3.1.6 Use of further doses of medication
3.2 Specific behaviours
3.2.1 Self-harm, including suicide
3.2.2 Injury to others*
3.2.3 Aggression
3.2.3.1 No clinically important change in aggression*
3.2.3.2 Not any change in aggression
3.2.3.3 Average endpoint aggression score
3.2.3.4 Average change in aggression scores
3.2.4 Self care
3.2.4.1 No clinically important change in self care
3.2.4.2 Not any change in self care
3.2.4.3 Average endpoint self care score
3.2.4.4 Average change in self care scores
3.2.5 Compliance
3.2.5.1 No clinically important change in compliance
3.2.5.2 Not any change in compliance
3.2.5.3 Average endpoint compliance score
3.2.5.4 Average change in compliance scores
4. Mental state
4.1 General mental state
4.1.1 No clinically important change in general mental state*
4.1.2 Not any change in general mental state
4.1.3 Average endpoint general mental state score
4.1.4 Average change in general mental state scores
5. Engagement with services
5.1 No clinically important engagement
5.2 Not any engagement
5.3 Average endpoint engagement score
5.4 Average change in engagement scores
6. Adverse effects
6.1 No clinically important general adverse effects
6.2 Not any general adverse effects
6.3 Average endpoint general adverse effect score
6.4 Average change in general adverse effect scores
6.5 No clinically important change in specific adverse effects
6.6 Not any change in specific adverse effects
6.7 Average endpoint specific adverse effects
6.8 Average change in specific adverse effects
7. Prison and service outcomes
7.1 Treatment of people in the community
7.2 Duration of treatment programme
7.3Changes in services provided by through care/probation teams
7.4 Changes of level of supervision by staff/police (re sex offender
registration etc.)
8. Satisfaction with treatment
8.1 Recipient of treatment not satisfied with treatment**
8.2 Recipient of treatment average satisfaction score
8.3 Recipient of treatment average change in satisfaction scores
8.4 Informal treatment provider not satisfied with treatment*
8.5 Informal treatment providers’ average satisfaction score
8.6 Informal treatment provider’ average change in satisfaction
scores
8.7 Professional providers not satisfied with treatment
8.8 Professional providers’ average satisfaction score
8.9 Professional providers’ average change in satisfaction scores
9. Acceptance of treatment
9.1 Not accepting treatment**
9.2 Average endpoint acceptance score
9.3 Average change in acceptance score
10. Leaving the study early
10.1 For specific reasons (release, parole, move establishment,
changes in security status (for example, changes from HMP Cat-
egory B to Category C levels)
10.2 For general reasons
11. Quality of life
11.1 No clinically important change in quality of life
11.2 Not any change in quality of life
11.3 Average endpoint quality of life score
11.4 Average change in quality of life scores
11.5 No clinically important change in specific aspects of quality
of life
11.6 Not any change in specific aspects of quality of life
11.7 Average endpoint specific aspects of quality of life
11.8 Average change in specific aspects of quality of life
12. Recidivism
12.1 Time before re-offence
12.2 Any offence
13. Substance Use
13.1 Change in illicit drug use or in abuse of prescribed drugs
13.2 Change in alcohol use
14. Changes in employment status
14.1 Gaining employment
14.2 Retaining employment
14.3 Losing employment
15 Economic outcomes
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15.1 Direct costs
15.2 Indirect costs
We divided outcomes into immediate (within 6 months), short
term (>6 months to 24 months) and medium term (>24 months
to 5 years) and long term (beyond 5 years).
N.B. Trials that provided data for this review reported outcomes
for intervals.
* Primary outcomes for immediate and short term.
** Primary outcomes for medium term.
Search methods for identification of studies
1. Electronic searches
1.1 ASSIA: we searched Applied Social Sciences Index and Ab-
stracts (1987-October 2002) using the phrase:
(de=((antisocial personality disorder) OR (avoidant personality
disorders) OR (borderline personality disorder) OR (dependent
personality) OR (depressive personality disorders) OR (gender
identity disorder) OR (histrionic personality disorder) OR (multi-
impulsive personality disorder)OR (multiple personality disorder)
OR (narcissistic personality disorder) OR (passive-aggressive per-
sonality disorder) OR (sadistic personality disorder) OR (schizo-
typal personality disorders) OR (self defeating personality disor-
der) OR (antisocial behaviour))) OR (((parano* NEAR person*)
OR ((asocial* OR antisocial* OR dissocial* OR psychopath* OR
sadist* OR sociopath*) NEAR person*)or (psychopath OR so-
ciopath OR (moral NEAR insanity) OR dissocial)) OR (diag-
nostic within 2 statistical manual iii) OR (diagnostic within 2
statistical manual iv) OR (diagnostic within 2 statistical manual
ii)) and (ab=(random*) OR ti=(random*) OR de=(randomi?ed
controlled trials) OR ab=(double* blind*)or ti=(double* blind*)or
de=(double blind studies) OR (single* NEAR blind*))
1.2 BHI: we searched British Humanities Index (1962 to October
2002) using the phrase:
(de=((antisocial behaviour) OR (psychopaths)) OR ((personal-
ity NEAR disorder*) OR (gender NEAR identity)) OR ((sadis-
tic OR schizotypal OR selfdefeating OR borderline OR avoidant
OR dependent OR depressive OR histrionic ORmulti-impulsive
OR multiple OR narcissistic OR passive-aggressive) NEAR (per-
son*)) OR ((parano* NEAR person*) OR (asocial* OR antiso-
cial* OR dissocial* OR psychopath* OR sadist* OR sociopath*)
NEAR (person*)) OR (psychopath OR sociopath OR (moral
NEAR insanity) OR dissocial) OR (diagnostic NEAR statisti-
cal NEAR manual*)) and (ab=(random*) OR ti=(random*) OR
de=(random) OR ab=(double* blind*) OR ti=(double* blind*)or
de=(double* blind*) OR (single* NEAR blind*))
1.3 BIOSIS: we searched BIOSIS (1985 to October2002) using
the phrase:
((al: ((randomi* OR crossover OR random-assignment) OR
((singl* OR doubl* OR tripl* OR trebl*) and (mask* OR
blind*)))) and (((((((histrionic OR multi-impulsive OR multiple
ORnarcissistic OR passive-aggressive)) OR ((psychopath*OR so-
ciopath*ORdissocialOR sadis*OR schizotypalOR self-defeating
OR borderline OR avoidant OR dependent OR depressive)))))
and (person*))) OR (((((((((moral and insanity) OR (moral and
insanity)) OR ((asocial* OR antisocial* OR dissocial* OR psy-
chopath* OR sadist* OR sociopath*) and person*)) OR (self and
defeating)) OR (parano* and person*)) OR (gender and identity))
OR (personality and disorder)) OR (antisocial and behaviour))))))
1.4 C2-SPECTR (http://128.91.198.137/RIS/
RISWEB.ISA#TOPOFREFLIST) (September 2002) SPECTR is
a registry of over 10,000 randomised and possibly randomised tri-
als in education, social work and welfare, and criminal justice and
we searched this using the phrase:
((antisocial OR avoidant OR borderline OR dependent OR de-
pressive OR histrionic OR impulsive ORmultiple OR narcissistic
OR paran OR psychopa OR sadistic OR schizotypal OR self-de-
feating OR sociopath) AND person) OR (gender AND identity)
OR (passive AND aggressive) OR (antisocial AND behav) OR
(moral AND insanity) OR (asocial OR antisocial OR dissocial
OR psychopath OR sadist OR sociopath)
1.5 CareData: we searched this database of social work and social
care literature (1985 to November 2002) using the phrase:
(randomi* OR (double* AND blind*) OR (control* AND clini-
cal*))
We downloaded the results into a Procite5 database and searched
again using the terms:
(antisocial* OR asocial* OR avoidant OR borderline OR depen-
dent OR depressive OR dissocial OR dissocial* OR histrionic
ORmoral ORmulti-impulsive ORmultiple* OR narcissistic OR
parano* OR passive-aggressive OR psychopath* OR sadis* OR
schizotypal OR self-defeating OR sociopath*)
1.6 CINAHL: we searched (1982 to January 2003) using the
phrase:
exp personality disorders/OR exp antisocial personality disorder/
OR exp borderline personality disorder/ OR exp compulsive per-
sonality disorder/OR exp dependent personality disorder/OR exp
impulse control disorders/OR exp passive-aggressive personality
disorder/ OR (histrionic$ adj2 person$) OR (parano$ adj2 per-
son$).mp. OR (schizo$ adj2 person$) OR ((asocial$ OR antiso-
cial$ OR dissocial$ OR psychopath$ OR sadist$ OR sociopath$)
adj2 person$) OR (psychopath OR sociopath OR (moral adj2 in-
sanity) OR dyssocial OR (DSM and (Axis and II)))
1.7 Cochrane CENTRAL Register of Controlled Trials: we
searched (October 2002) using the phrase:
[(antisocial-personality-disorder*:me OR personality-
disorders*:meOR sexual-and-gender-disorders*:meORmultiple-
personality-disorder*:me OR paraphilias*:me) OR (multi-impul-
sive and personality) OR (parano* NEAR person*) OR (asocial*
NEAR person) OR (dissocial* NEAR person) OR (psychopath*
NEARperson)OR (sadist*NEARperson)OR (sociopath*NEAR
person*) OR (moral NEAR insanity) OR ((personality and disor-
der*) and ((((avoidant OR multi-impulsive) OR narcissistic) OR
self-defeating) OR personality)]
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1.8 Cochrane Schizophrenia Groups Register of trials related to
Forensic Mental Health Services (2000): we searched this using
the phrase:
(psychopath* OR sociopath* OR dissocial OR sadis* OR schizo-
typal OR self-defeating OR borderline OR avoidant OR depen-
dent OR depressive OR histrionic OR multi-impulsive OR mul-
tiple OR narcissistic OR passive-aggressive) AND (person*) OR
(antisocial ANDbehaviour) OR (personality ANDdisorder*) OR
(gender AND identity) OR (parano* AND person*) OR (self
AND defeating) OR ((asocial* or antisocial* or dissocial* or psy-
chopath* or sadist* or sociopath*) AND person*) OR (moral
AND insanity)
1.9 COPAC: we searched the Consortium of University Re-
search Libraries joint catalogue (October 2002) using the follow-
ing terms:
randomi* OR ((double OR single OR triple OR treble) and blind)
OR prospective OR (clinical and trial)
We then downloaded results into a Procite5 database and searched
again using the terms:
(antisocial* OR asocial* OR avoidant OR borderline OR depen-
dent OR depressive OR dissocial OR dissocial* OR histrionic
ORmoral ORmulti-impulsive ORmultiple* OR narcissistic OR
parano* OR passive-aggressive OR psychopath* OR sadis* OR
schizotypal OR self-defeating OR sociopath*)
1.10 CORDIS: we searched the Community Research and Devel-
opment Information Service (1986 to November 2002) with the
phrase:
(randomi* OR (double and blind) OR (controlled and trial).
We read entries on the web page and downloaded relevant records.
1.11 Criminal Justice Periodical Index: we searched (1968 to
November 2002) using the phrase:
(((personality-disorder) OR (personality-disordered)) OR ((anti-
social-person)OR (antisocial-manipulator)OR (antisociality)OR
(antisocially) OR (antisocials)) OR ((psychopath) OR (psycho-
pathic) OR (psychopathic-deviant) OR (psychopathic-deviate)
OR (psychopathically) OR (psychopaths-) OR (psychopathy) OR
(psychopathy-)) OR (personality-disorder) OR (borderlines) OR
(borderlines) OR (histrionicity) OR ((narcissistic) OR (narcissisti-
cally)) OR (passive-aggressive) OR ((sadistically) OR (sadists) OR
(sado-masochism) OR (sado-masochistic) OR (sadomascochism)
OR (sadomasochism) OR (sadomasochistic)) OR (schizotypy)
OR (((asocial* OR antisocial* OR dissocial* OR psychopath* OR
sadist*OR sociopath*) near person*)or (psychopathORsociopath
OR (moral near insanity) OR dissocial))) and (((single blind OR
double blind OR triple blind OR treble blind OR randomi* OR
randomised OR randomized OR controlled trial) OR ((random-
assignment) OR (random-design) OR (randomization) OR (ran-
domize) OR (randomized) OR (randomized-groups) OR (ran-
domly-selected))) OR (double-blind) OR ((blind-treatment) OR
(blinded) OR (blinding)) OR ((controls) OR (controlled)))
1.12 Dissertation Abstracts: we searched (Digital Dissertations
1861 to December 2002) using the phrase:
((randomi?w/2 control?) OR (triple w/1 blind?) OR (double
w/1 blind?) OR (treble w/1 blind?) OR (single w/1 blind?)
OR ab(double blind?) OR ab(randomi?) OR (controlled clinical
trial)) and ((asocial?OR antisocial?OR dissocial?OR psychopath?
OR sadist? OR sociopath?OR histrionic OR multi-impulsive OR
multiple? OR narcissistic) and person?) OR ((passive-aggressive
ORpsychopath?OR sociopath?ORdissocialOR sadis?OR schizo-
typal OR self-defeating OR borderline OR avoidant OR depen-
dent OR depressive OR parano?) and person?) OR ((moral and
insanity) OR (self and defeating) OR (gender and identity) OR
(personality and disorder) OR (antisocial and behaviour))
1.13 EMBASE: we searched (1980 to January 2003) using the
phrase:
exp personality disorder/ OR exp borderline state/ OR exp char-
acter disorder/ OR exp compulsive personality disorder/ OR exp
delusion/ OR exp dependency/OR exp depersonalization/OR exp
jealousy/ OR exp kleptomania/OR exp multiple personality/OR
exp narcissism/OR exp psychopathy/OR exp schizoidism/OR exp
sociopathy/OR (antisoci$ adj2 person$) OR (aggres$ adj2 per-
son$) OR (border$ adj2 person$) ORhistrion$ person$ORpara-
noid person$ OR (passive adj2 aggressive) OR ((asocial$ OR
antisocial$ OR dissocial$ OR psychopath$ OR sadist$ OR so-
ciopath$) adj person$) OR (moral adj2 insan$) OR dyssocial OR
(DSM and (Axis and II))
1.14 Federal Research in Progress/CRSP: This is one of the
databases within the GRC database. See 1.15 below.
1.15 GOV.Research_Center: we searched (1964 to December
2002) using the phrase:
((randomi* OR (double and blind*)OR (control* and clinical and
trial*)) and ((antisocial OR avoidant OR borderline OR depen-
dentOR depressive ORhistrionic OR impulsive ORmultiple OR
narcissistic OR paran* OR psychopa* OR sadistic OR schizotypal
OR self-defeating OR sociopath) and person) OR (gender and
identity) OR (passive and aggressive) OR (antisocial and behav)
OR (moral and insanity) OR (asocial OR antisocial OR dissocial
OR psychopath OR sadist OR sociopath))
1.16 IBSS:we searched the International bibliography of the Social
Sciences (1951 to October 2002) using the phrase:
(randomi* OR double blind)
We then downloaded results into a Procite5Database and searched
this using the terms:
(antisocial* OR asocial* OR avoidant OR borderline OR depen-
dent OR depressive OR dissocial OR dissocial* OR histrionic
ORmoral ORmulti-impulsive ORmultiple* OR narcissistic OR
parano* OR passive-aggressive OR psychopath* OR sadis* OR
schizotypal OR self-defeating OR sociopath*)
1.17 ISI - Proceedings (instead of ISI-ISTP): we searched (1990
to October 2002) using the phrase:
(double blind OR randomi*) AND ((passive-aggressive OR psy-
chopath* OR sociopath* OR dissocial OR sadis* OR schizotypal
OR self-defeatingORborderlineOR avoidant ORdependentOR
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depressive OR parano* OR asocial* OR antisocial* OR dissocial*
OR psychopath* OR sadist* OR sociopath* OR histrionic OR
multi-impulsive OR multiple* OR narcissistic) AND personal-
ity*) OR ((moral AND insanity) OR (self AND defeating) OR
(gender AND identity) OR (personality AND disorder) OR (an-
tisocial AND behaviour))
1.18 ISI-SCI: we searched the Science Citation Index Expanded
(1981 to November 2002) using the phrase:
(double blind OR randomi*) AND ((passive-aggressive OR psy-
chopath* OR sociopath* OR dissocial OR sadis* OR schizotypal
OR self-defeatingORborderlineOR avoidant ORdependentOR
depressive OR parano* OR asocial* OR antisocial* OR dissocial*
OR psychopath* OR sadist* OR sociopath* OR histrionic OR
multi-impulsive OR multiple* OR narcissistic) AND personal-
ity*) OR ((moral AND insanity) OR (self AND defeating) OR
(gender AND identity) OR (personality AND disorder) OR (an-
tisocial AND behaviour))
1.19 ISI-SSCI: we searched Social Sciences Citation Index (1981
to November 2002) using the phrase:
(double blind OR randomi*) and ((passive-aggressive OR psy-
chopath* OR sociopath* OR dissocial OR sadis* OR schizotypal
OR self-defeatingORborderlineOR avoidant ORdependentOR
depressive OR parano* OR asocial* OR antisocial* OR dssocial*
OR psychopath* OR sadist* OR sociopath* OR histrionic OR
multi-impulsive OR multiple* OR narcissistic) and personality*)
OR ((moral and insanity) OR (self and defeating) OR (gender
and identity) OR (personality and disorder) OR (antisocial and
behaviour))
1.20 MEDLINE: we searched (1966 to January 2003) using the
phrase:
[exp personality disorders/OR exp antisocial personality disorder/
OR exp borderline personality disorder/ OR exp compulsive per-
sonality disorder/OR exp dependent personality disorder/OR exp
histrionic personality disorder/ OR exp hysteria/OR exp paranoid
personality disorder/ OR exp passive-aggressive personality disor-
der/ OR exp schizoid personality disorder/ OR exp schizotypal
personality disorder/ OR ((asocial$ OR antisocial$ OR dissocial$
OR psychopath$ OR sadist$ OR sociopath$) adj2 person$) OR
psychopath OR sociopath OR (moral adj2 insanity) OR dyssocial
OR (DSM and (axis and II))]
1.21 National Criminal Justice Reference Service Abstracts
Database: we searched (1970 toNovember 2002) using the phrase:
(randomi* OR double blind) and (antisocial* OR asocial* OR
avoidant OR borderline OR dependent OR depressive OR disso-
cial OR dissocial* OR histrionic OR moral OR multi-impulsive
OR multiple* OR narcissistic OR parano* OR passive-aggressive
OR psychopath*OR sadis* OR schizotypal OR self-defeatingOR
sociopath*)
1.22 National Research Register: we searched (Issue 3 2002) using
the phrase:
(antisocial-personality-disorder*:me OR (self AND (near3 AND
defeating))OR (antisocial ANDbehaviour)OR (self ANDdefeat-
ing) OR (parano* NEAR person*) or((((((asocial* OR antisocial*)
OR dissocial*) OR psychopath*) OR sadist*) OR sociopath*)
NEAR person*) OR (((((asocial* OR antisocial*) OR dissocial*)
OR psychopath*) OR sadist*) OR sociopath*) OR (moral NEAR
insanity) OR (((psychopath OR sociopath) OR (moral NEAR in-
sanity)) OR dissocial)) AND (randomized-controlled-trials*:me
OR double-blind-method*:me OR single-blind-method*:me OR
controlled-clinical-trial*:me OR randomi* OR ((double OR sin-
gle OR triple OR treble) AND blind)
1.23 PSYCINFO: we searched (1872 to December 2002) using
the phrase:
[((((personality disorders/OR exp antisocial personality/OR exp
avoidant personality/OR exp borderline personality/OR exp de-
pendent personality/OR exp histrionic personality disorder/ OR
exp narcissistic personality/OR exp obsessive compulsive person-
ality/OR exp paranoid personality/OR exp passive aggressive per-
sonality/OR exp sadomasochistic personality/OR exp schizoid
personality/OR exp schizotypal personality/) OR (((Personality
adj disorders) OR (antisocial adj personality) OR (avoidant adj
personality) OR (borderline adj personality) OR (dependent adj
personality) OR (histrionic adj (personality AND disorder)) OR
(narcissistic adj personality) OR (obsessive adj (compulsive AND
personality)) OR (paranoid adj personality) OR (passive adj (ag-
gressive AND personality)) OR (sadomasochistic adj personality)
OR (schizoid adj personality) OR (schizotypal adj personality)
and combined with the Cochrane Schizophrenia Groups search
strategy for controlled clinical trials]
1.24 REGARD: we searched (1980’s to November 2002) using
the phrase:
(randomi* OR (double AND blind) OR (single AND blind) OR
(control* AND trial))
We then downloaded results into a Procite5Database and searched
using the terms:
(personality* OR antisocial* OR avoidant* OR borderline* OR
dependent* OR histrionic* OR narcissistic* OR obsessive* OR
compulsive* OR paranoid* OR passive* OR aggress* OR sado-
masochistic* OR schizo*)
1.25 SIGLE: we searched System for Information on Grey Liter-
ature in Europe (1980 - November 2002) using the phrase:
((randomisation) OR (randomised) OR (randomisee) OR (ran-
domises) OR (randomize) OR (randomized) OR (randomly) OR
((double AND blind) OR double-blind OR double* blind* OR
randomi?ed controlled trials)) AND((psychopath*ORsociopath*
OR dissocial OR sadis* OR schizotypal OR self-defeating OR
borderline OR avoidant OR dependent OR depressive OR histri-
onic OR multi-impulsive OR multiple OR narcissistic OR pas-
sive-aggressive) AND (person*) OR (antisocial AND behaviour)
OR (personality AND disorder*) OR (gender AND identity) OR
(parano* AND person*) OR (self AND defeating) OR ((asocial*
OR antisocial* OR dissocial* OR psychopath* OR sadist* OR
sociopath*) AND person*) OR (moral AND insanity))
1.26 Sociological Abstracts: we searched (1963 to November
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2002) using the phrase:
(((personality* OR antisocial* OR avoidant* OR borderline* OR
dependent* OR histrionic* OR narcissistic* OR obsessive* OR
compulsive* OR paranoid* OR passive* OR aggress* OR sado-
masochistic* OR schizo*) near disorder) OR ((personality* OR
antisocial* OR avoidant* OR borderline* OR dependent* OR
histrionic* OR narcissistic* OR obsessive* OR compulsive* OR
paranoid* OR passive* OR aggress* OR sadomasochistic* OR
schizo*) AND disorder)) AND (AB=randomi* OR TI=random*
OR DE=(randomi?ed controlled trials) OR AB=(double* blind*)
ORTI=(double* blind*) ORDE=(double blind studies) OR (sin-
gle* near blind*))
1.27 ZETOC: we searched this database (1993 to November
2002) using the phrase:
(personality* OR antisocial* OR avoidant* OR borderline* OR
dependent* OR histrionic* OR narcissistic* OR obsessive* OR
compulsive* OR paranoid* OR passive* OR aggress* OR sado-
masochistic* OR schizo*)
We then downloaded results into a Procite5Database and searched
using the terms:
(randomi* or blind* or control*)
2. Hand searching
We searched reference lists of included and excluded studies for
additional relevant trials. Specific journals not previously hand
searched, which gave a high yield of studies were to have been
hand searched.
3. Requests for additional data
We contacted authors of relevant studies to enquire about other
sources of information and the first author of each included study
for information regarding unpublished data.
Data collection and analysis
1. Study selection
CB and TL inspected all electronic reports and these were re-in-
spected by a second reviewer (LMcC) in order to ensure reliable
selection. Where disagreement occurred we resolved this by dis-
cussion or, if doubt remained, we acquired the full article for fur-
ther inspection. Once we obtained the full articles the two review-
ers, again working independently, decided whether they met the
criteria for inclusion. Again, when disputes arose, we attempted
resolution by discussion but if this was not possible we did not
enter data and allocated the trial to the list of those awaiting as-
sessment whilst contacting authors. MF re-extracted data, again
working independently.
2. Assessment of quality
Again working independently, we allocated trials to three quality
categories, as described in the Cochrane Collaboration Handbook
(Clarke 2002). When disputes arose as to which category a trial
was to be allocated, again, we attempted resolution by discussion.
When this was not possible, we excluded studies of possible cate-
gory C until further details became available. We hoped to include
only trials in category A or B in the review.
3. Data management
3.1 Data extraction
CB, LMcC and MF, all working independently, extracted data
from selected trials. When disputes arose we resolved this by dis-
cussion. When this was not possible and we needed further infor-
mation to resolve the dilemma, we did not enter data and added
this outcome of the trial to the list of those awaiting assessment.
3.2 Intention to treat analysis
We excluded data from studies where more than 50% of partici-
pants in any group were lost to follow-up. In studies with less than
50% drop out rate, we considered people leaving early to have had
the negative outcome, except for adverse effects such as death.
We analysed the impact of including studies with high attrition
rates (25 to 50%) in sensitivity analyses. If inclusion of data from
this group did result in a substantive change in the estimate of
effect of the primary outcomes, we did not add data from these
studies to trials with less attrition, but presented them separately.
4. Data analysis
4.1.1 Binary data
For binary outcomes we calculated a standard estimation of the
fixed effects ratio (RR) and its 95% confidence interval (CI).
Where possible, for results that reached conventional levels of sta-
tistical significance, we calculated the weighted number needed to
treat/harm statistic (NNT/H), and its confidence interval (CI).
4.1.2 Valid scales: we included data from rating scales only if the
measuring instrument had been previously described in a peer-
reviewed journal (Marshall 2000a) and the instrument was either
a self-report or completed by an independent rater or relative (not
the therapist).
4.2. Continuous data
4.2.1 Skewed data: continuous data on clinical and social out-
comes are often not normally distributed. To avoid the pitfall of
applying parametric tests to non-parametric data, we applied the
following standards to all data before inclusion: (a) standard de-
viations and means were reported in the paper or were obtainable
from the authors; (b) when a scale started from the finite number
zero, the standard deviation, whenmultiplied by two, was less than
themean (as otherwise the mean was unlikely to be an appropriate
measure of the centre of the distribution (Altman 1996); (c) if a
scale started from a positive value (such as PANSS which can have
values from 30 to 210) the calculation described above was mod-
ified to take the scale starting point into account. In these cases
skew is present if 2SD>(S-Smin), where S is the mean score and
Smin is the minimum score. Endpoint scores on scales often have
a finite start and end point and these rules can be applied to them.
When continuous data are presented on a scale which includes
a possibility of negative values (such as change on a scale), there
is no way of telling whether data are non-normally distributed
(skewed) or not. It is thus preferable to use scale end point data,
which typically cannot have negative values. If end point data were
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not available, the reviewers would have used change data, but not
subjected them tometa-analysis, and reported them in ’Additional
data’ tables.
4.2.2 Summary statistic: for continuous outcomes we estimated
a fixed effects weighted mean difference (WMD) between groups
and the 95% CI. Again, if we found heterogeneity (see Section 5)
we employed a random effects model.
4.2.3 Valid scales: we included continuous data from rating scales
only if the measuring instrument had been previously described
in a peer-reviewed journal (Marshall 2000a) and the instrument
was either a self-report or completed by an independent rater or
relative (not the therapist).
4.2.4 Endpoint versus change data: where possible we present
endpoint data and if both endpoint and change data had been
available for the same outcomes then only the former would have
been reported in this review.
4.2.5 Cluster trials: studies increasingly employ ’cluster randomi-
sation’ (such as randomisation by clinician or practice) but analy-
sis and pooling of clustered data poses problems. Firstly, authors
often fail to account for intra class correlation in clustered stud-
ies, leading to a ’unit of analysis’ error (Divine 1992) - whereby p
values are spuriously low, confidence intervals unduly narrow and
statistical significance overestimated - causing type I errors (Bland
1997; Gulliford 1999). Secondly, RevMan does not currently sup-
port meta-analytic pooling of clustered dichotomous data, even
when these are correctly analysed by the authors of primary stud-
ies, since the ’design effect’ (a statistical correction for clustering)
cannot be incorporated.
Where clustering was not accounted for in primary studies, we
presented the data in a table, with a (*) symbol - to indicate the
presence of a probable unit of analysis error. Subsequent versions
of this review will seek to contact first authors of studies to seek
intra-class correlation co-efficients of their clustered data and to
adjust for this using accepted methods (Gulliford 1999). Where
clustering has been incorporated into the analysis of primary stud-
ies, then we would also have presented these data as if from a non-
cluster randomised study, but adjusted for the clustering effect.
We have sought statistical advice and have been advised that the
binary data as presented in a report should be divided by a ’design
effect’. This is calculated using the mean number of participants
per cluster (m) and the intraclass correlation co-efficient (ICC)
[Design effect = 1+(m-1)*ICC] (Donner 2002). If the ICC was
not reported it was assumed to be 0.1 (Ukoumunne 1999).
If cluster studies had been appropriately analysed taking into ac-
count intra-class correlation coefficients and relevant data docu-
mented in the report, synthesis with other studies would have been
possible using the generic inverse variance technique.
5. Test for heterogeneity
Firstly, we undertook consideration of all the included studies
within any comparison to estimate clinical heterogeneity. Then
we used visual inspection of graphs to investigate the possibility
of statistical heterogeneity. We supplemented this by employing,
primarily, the I-squared statistic. This provides an estimate of the
percentage of inconsistency thought to be due to chance. Where
the I-squared estimate included 75% this was interpreted as ev-
idence of high levels of heterogeneity (Higgins 2003). We then
reanalysed data using a random effects model to see if this made
a substantial difference. If it did, and results became more con-
sistent, falling below 75% in the estimate, the studies were added
to the main body trials. We did not summate data if using the
random effects model did not make a difference and inconsistency
remained high, but presented the data separately and investigated
and discussed reasons for heterogeneity.
6. Addressing publication bias
With more included studies we would have entered data from all
included studies into a funnel graph (trial effect against trial size)
in an attempt to investigate the likelihood of overt publication
bias (Egger 1997).
7. Sensitivity analyses
We were to have analysed the effect of including studies with high
attrition rates in a sensitivity analysis. Where a trial was described
as ’double-blind’ but implied that the study was randomised, these
trials were also to have been included in a sensitivity analysis. We
were to have compared results of studies using Grade A diagnoses
with those using Grade B labels (primary outcomes only).
8. General
We entered data in such a way that the area to the left of the line
of no effect indicated a favourable outcome for the intervention.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies.
For substantive descriptions of studies please see Included and
Excluded studies tables.
1. Excluded
In a review such as this there is always an issue of what to report
in the excluded studies section. Thousands of electronic reports
are identified but reporting on the great majority of those in this
section would, we feel, do no service to the reader.We selected very
few of the studies identified by the searches for closer inspection as
abstracts and titles made it quite clear that the work was not rele-
vant for inclusion. We identified 56 reports for further inspection
and had to exclude 49. Themajority of these were either case study
or case series. Dolan 1996, however, is a prospective survey of ser-
vice usage, after treatment. Eckert 2000 is a follow-up study in-
vestigating long-term changes of the symptoms of 14 people with
the diagnosis borderline personality disorder (criteria by Kernberg
and Rorschach test) and comparing this group with 13 patients
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with diagnosis schizophrenia and 16 with depression (Kernberg
1967). People with a borderline disorder were treated in client-
centred group psychotherapy (twice a week, approximately 100
sessions). James 1996 matched 24 adolescents diagnosed as having
borderline personality disorder to psychiatric controls. Joyce 1999
undertook cluster analysis to identify subgroups of a sample of 40
patients with borderline personality disorder. Links 1998 was a
prospective cohort study of 57 people with borderline personality
disorder, followed up for seven years and reassessed for presence of
symptoms. McGlashan 1986 assessed 81 people from the Chest-
nut Lodge follow-up study and compared them with people from
different cohorts diagnosed with schizophrenia (n=163) or unipo-
lar affective disorder (n=44). Meares 1999 was another non-ran-
domised cohort study of participants with borderline personality
disorder who received twice weekly psychotherapy sessions over a
one year period and compared this group with people on a wait-
ing list control. Munroe-Blum 1995 was a randomised controlled
trial of 110 participants with diagnosis of borderline personality
disorder. Unfortunately data were not reported by treatment allo-
cation making them impossible touse. Najavits 1995 was a three
year prospective naturalistic study of 37 women with borderline
personality disorder but involved no control. Sandell 1993 fol-
lowed up all attendees at a day hospital at three to ten years and
compared people who stayed in treatment to those who left by
four months and compared then to a group of people who were
felt to represent the functional norm. Stanley 1998 is a prospec-
tive, matched control study. Stevenson 1992 is a cohort study
of 30 people whose cost of care was compared before and after
treatment with twice weekly out-patient psychotherapy. Wilberg
1998 was a prospective, naturalistic study designed to evaluate the
practice and effectiveness of an outpatient group therapy program
following day treatment for people with personality disorders and
included 180 participants who were treated in outpatient psycho-
dynamic group therapy. There was, however, no control group
in this study. Yeomans 1993 was a pilot study on the process of
psychodynamic psychotherapy of borderline personality disorder
and was designed to investigate the teaching and application of a
model of treatment for borderline patients. The project involved
teaching a group of self-selected trainees and faculty manualised
therapy and the outcome was adherence to the model. They used
no control treatment.
2. Included studies
We identified seven studies for inclusion in this review (Bateman
1999; Koons 2001; Linehan 1991; Linehan 1999; Linehan 2002;
Turner 2000; van den Bosch 2002).
2.1 Length of trials
Bateman 1999 randomised people for a maximum of 18 months
(average of 1.45 years). Koons 2001 was of six months duration.
Linehan 1991, Linehan 1999, Linehan 2002, Turner 2000 and
van den Bosch 2002 were all for one year. Linehan 1991 reports
limited data on follow-up from 12 months. These data are mostly
impossible to use as they are on a sub-set of participants rather
than the full group. Bateman 1999 reports data up to three years
and is analysing four year data at this time (2004).
2.2 Participants
Two hundred and sixty two people were entered into seven studies,
over five separate comparisons
The great majority of people in Bateman 1999, Koons 2001,
Linehan 1991, Linehan 1999, Linehan 2002, and van den Bosch
2002 were women with operationally diagnosed borderline per-
sonality disorder diagnosed using the SCID-II (Structured Clin-
ical Interview for DSM-III-R for Axis II) or/and the Diagnostic
Interview for Borderline Patients or the Personality Diagnostic
Questionnaire, Diagnostic Statistical Manual-IV version. Turner
2000 involved predominately men meeting borderline personal-
ity disorder criteria using the Diagnostic Interview for Borderlines
and Personality Disorders Examination.
Studies often allowed co-morbid conditions such as major de-
pression, dysthymia panic disorder, agoraphobia, sociophobia and
bulimia. Participants in Linehan 1991 had a history of at least
2 incidents of parasuicide in the last five years (1 in the last 8
weeks) and did not meetDSM-III criteria for schizophrenia, bipo-
lar disorder, substance dependence or mental retardation. Women
in Linehan 1999 also met criteria for substance use disorder for
opiates, cocaine, amphetamines, sedatives, hypnotics, anxiolytics,
or poly-substance use disorder on SCID-II; 12% of sample diag-
nosed with antisocial personality disorder; and excluded if met cri-
teria for schizophrenia, another psychotic disorder, bipolar mood
disorder or mental retardation. Nineteen of the twenty four were
taking psychotropic medication at beginning of the study period.
In Linehan 2002 participants also had a diagnosis of current opiate
dependence (SCID-I), 52% also met criteria for dependence on
cocaine, 13%on sedatives, 8.7% on cannabis and 26%on alcohol.
65% reported at least one suicide attempt self injury. 44%met cri-
teria for antisocial personality disorder. Reasons for exclusion were
bipolar disorder, psychosis, seizure disorder or mental retardation.
In Turner 2000 everyone was initially treated in hospital following
a suicide attempt. Those excluded included those with a diagnosis
of schizophrenia, schizoaffective disorder, organic mental disorder
and mental retardation. Many participants met criteria for a co-
morbid disorder (23/24 [17 dysthymia generalised anxiety disor-
der; 18 met criteria for 2 additional personality disorders (9 de-
pendent, 6 histrionic, 3 schizotypal, 2 paranoid, 2 antisocial, and
1 compulsive personality disorder]). Nineteen participants were
also taking psychotropic medication at the pre-assessment stage of
the study. In van den Bosch 2002 there was no one with DSM-IV
diagnosis of bipolar disorder or (chronic) psychotic disorder and
severe cognitive impairments. Thirty one of the fifty eight par-
ticipants who started treatment in this study abused substances.
Referrals to the study were primarily from addiction treatment
and psychiatric services. Seventy five percent of participants within
each treatment condition used psychotropic medication (benzo-
diazepines, antidepressants, mood stabilisers, and neuroleptics
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2.3 Setting
Bateman 1999 provided partial hospitalisation in a day hospital,
whilst all other studies took place in the outpatient setting.
2.4 Study size
All studies are small (Bateman 1999 n=44, Koons 2001 n=28,
Linehan 1991 n=63, Linehan 1999 n=28, Linehan 2002 n=23,
Turner 2000 n=24, van den Bosch 2002 n=64).
2.5 Interventions
2.5.1 Psychoanalytically oriented partial hospitalisation
Bateman 1999 randomised people to psychoanalytically oriented
partial hospitalisation. They undertook therapy over a five day
cycle of once-weekly individual psychoanalytic psychotherapy;
thrice-weekly group analytic psychotherapy (1 hour each); once-
a week expressive therapy orientated towards psychodrama tech-
niques (1 hour) along with a weekly community meeting (1 hour).
Once a month participants met with a case administrator (1 hour)
and reviewed medication (antidepressants and antipsychotics as
required).
2.5.2 Dialectical behaviour therapy
Koons 2001 used dialectical behaviour therapy (DBT) which con-
sisted of individual therapy (prioritised hierarchy of target be-
haviours, telephone coaching with individual therapists between
sessions) and groups skills training lasting 90 minutes a week for
6 months. In Linehan 1991, DBT was given weekly individu-
ally for one hour. This was along with behavioural skill train-
ing, contingency management, cognitive modification, exposure
to emotional cues, reflection, empathy, acceptance and group ther-
apy lasting 2.5 hours. The latter consisted of psycho-educational
training and teaching of behavioural skills for one year. Linehan
1999 gave dialectical behaviour therapywith core elements of stan-
dard manualised DBT modified for a substance abusing popula-
tion. This consisted of weekly individual psychotherapy for one
hour, group skills training for 2 hours 15 minutes, skills coach-
ing, phone calls with individual therapist (as required) and ’transi-
tional maintenance’ a replacement medication protocol for stim-
ulant and opiate dependent people, with treatment lasting 1 year.
Linehan 2002 gave dialectical behaviour therapy core elements
of which were again of standard manualised DBT but this time
modified for a substance abusing population. This consisted of
weekly individual DBT sessions for 40-90 minutes a week, target-
ing dysfunctional behaviours, replacing these with skills learned
in psycho-educational skills group, phone consultation and cri-
sis intervention as needed plus weekly groups skills training for
150 minutes a week, which contained skills training of mindful-
ness, interpersonal effectiveness, distress tolerance and regulation
of emotion. Each participant also had recommended individual
skills coaching (skills strengthening and generalization), the 12-
step treatment programme for Alcoholics / Narcotics / Cocaine
Anonymous (AA, NA, CA) or other support groups. This was
paired with opiate replacement medication (levomethadyl acetate
hydrochloride). Turner 2000 gave dialectical behaviour therapy
oriented treatment, based on the above, but with modifications
which incorporated psychodynamic techniques and no separate
DBT skills training group, skills training during individual ther-
apy and six group sessions focusing on significant people in their
environment. Finally, van den Bosch 2002 also gave dialectical be-
haviour therapy which was a manualised 12 month treatment pro-
gramme, comprising of weekly individual cognitive behavioural
psychotherapy to address motivational issues, a weekly group skills
training lasting 2-2.5 hours a week, concentrating on self-regula-
tion and change skills and self and other acceptance and phone
consultation as needed (coaching in application of new skills.
2.5.3 Comprehensive validation therapy
In Linehan 2002 the comparator programme was comprehensive
validation therapy (CVT) and the 12-step treatment programme
for Alcoholics / Narcotics / Cocaine Anonymous (CVT+12S).
People got individual CVT+12S for 40-90 minutes a week, DBT
acceptance-based non-directive strategies and ’12-and-12’ Nar-
cotics Anonymous (NA) group for 120 minutes a week. They rec-
ommended a 12-Step sponsor meeting and 12-Step (AA/NA/CA)
meetings. People in theCVT+12S groupwere also given caseman-
agement as needed and phone consultation, standard crisis inter-
vention and opiate replacement medication (levomethadyl acetate
hydrochloride).
2.5.4 Client centred therapy
Turner 2000 used client centred therapy as comparator to DBT.
This consisted of non-directive support to help patients cope with
daily stressors and to prevent relapse. There were four phases to
treatment; crisis management, problem assessment, and support-
ive treatment and termination. Treatment was scheduled for two
times per week over one year (up to three times a week during
crisis management).
2.5.5 Treatment as usual
The comparator in Koons 2001 was treatment as usual. This con-
sisted of being offered 60 minutes per week individual therapy and
supportive and psycho-educational groups with treatment lasting
6 months. In Linehan 1991, treatment as usual was referrals to
alternative therapy and 73% began individual therapy. In Linehan
1999, treatment as usual consisted of continuing with individual
psychotherapists, or being referred to alternative substance abuse
and/or mental health counsellors/programmes and meetings with
case managers as required. Treatment lasted one year. van den
Bosch 2002 used clinicalmanagement fromoriginal referral source
which was addiction treatment (n=11) or general psychiatric ser-
vices (n=20). Participants did not typically attend more than two
sessions per month with a practitioner.
2.5.6 General psychiatric care
Bateman 1999 used regular psychiatric review with senior psy-
chiatrist (average twice per month) as comparator. This involved
inpatient admission if required (90% with average stay of ~12
days), discharge to non-psychoanalytic psychiatric partial hospi-
talisation focused on problem solving (72% for an average of 6
months), and outpatient/community follow-up as standard after-
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care (100%, twice weekly visits byCommunity PsychiatricNurse).
2.6 Outcomes
2.6.1 Death
Linehan 1999 reports some data for the outcome of death.
2.6.2 Improvement
Bateman 1999 did not state a primary outcome of interest but
used acts of self harm, clinical and service measures and psychi-
atric symptoms for outcomes. Koons 2001 planned their project
as a pilot study to see if a trial similar to Linehan 1991 could be
replicated. Linehan 1991 set out their primary goal as reduction in
parasuicidal behaviour. Linehan 1999 set out to test whetherDBT
would reduce substance abuse and to adapt the DBT manual for
the population of substance abusing women. In Linehan 2002,
the primary aim was to test whether DBT was superior to com-
prehensive validation therapy plus a twelve step programme for
women abusing opiates. Turner 2000 did not pre-specify any pri-
mary outcome of interest and reported self harm/suicide severity
acts, mental state and behaviour as outcomes. van den Bosch 2002
set out to examine whether DBT can be successfully implemented
in a mixed population of people with borderline personality disor-
der, with or without substance misuse problems; whether DBT is
equally effective in reducing borderline symptoms for those with
and without co-morbid substance misuse and is, primarily, effec-
tive in reducing problems secondary to substance misuse.
2.6.3 Global
Koons 2001 dichotomises the number of people still meeting
SCID-II criteria and the average number of SCID-II criteria still
met at six months.
2.6.4 Behaviour
Bateman 1999 reported on anxiety state and traits using continu-
ous rating scales, whilst also reporting on depression, dichotomis-
ing the Beck Depression Inventory (BDI) at 14 points and above,
as well as reporting the continuous scale data. Bateman 1999
also reports on general psychopathology using continuous data
from the SCL-90 (Symptoms Check List 90). Koons 2001 and
Linehan 1991 both report number of self harm or parasuicide
events. Turner 2000 also reports six to 12 month data for parasui-
cide and behavioural indicators.
2.6.5 Mental state
Bateman 1999, Koons 2001, Linehan 1991and Turner 2000 all
report mental state outcomes. They use a variety of scales reported
in different ways.
2.6.6 Service outcomes
Bateman 1999, Koons 2001 and Turner 2000 report admission to
psychiatric hospital. Linehan 1991 reports the average number of
days in hospital and Linehan 2002 the average number of nights
incarcerated. Bateman 1999 also reports data for the average num-
ber of inpatient days, the average number of days partially hos-
pitalised, visits to outpatients and attending community outpa-
tients. Bateman 1999 also reports on the number of people taking
psychotropic medication and on the number of people receiving
multiple drugs.
2.6.7 Employment outcomes
Linehan 1991 reports continuous outcomes for work performance
measured using the SAS-SR (Social Adjustment Scale-Interview -
Self report).
2.6.8 Substance use
All results for substance use by 12 to 18 months are reported in
van den Bosch 2002. Linehan 1999 reports urinalysis testing and
abstinence.
2.6.9 Leaving the study early
Six studies reported numbers of people leaving the study early
(Bateman 1999; Koons 2001; Linehan 1991; Linehan 1999;
Linehan 2002; van den Bosch 2002).
2.6.10 Quality of life
Bateman 1999 reports on two areas of quality of life, using data
from the SAS-SR and the IIP-CV (Inventory of Interpersonal
Problems Circumplex Version). Linehan 1991 reports continuous
outcomes for an adjusted average score using the LIFE (Longi-
tudinal Interval Follow-up Evaluation) and SAS-I (Social Adjust-
ment Scale-Interview) global measure of change, as well as social
adjustment.
2.6.11 Outcome scales - Details of scales that provided usable
data are shown below. Reasons for exclusion of data from other
instruments are given under ’Outcomes’ in the ’Included studies’
section.
2.6.11.1 Global Functioning
a. Global Assessment Scale - GAS (Endicott 1976)
Used to evaluate the overall functioning of a person during a spec-
ified time period in terms of psychological well-being or sickness.
Time period assessed is generally one week prior to evaluation.
Scale covers entire range of severity and can be used in any situ-
ation or study where an overall evaluation of the severity of the
illness or degree of health is needed. The person is rated on a scale
from 0-100 which represents a continuum from psychological or
psychiatric sickness to health (high = good).
2.6.11.2 Mental state
a. Beck Anxiety Inventory BAI (Beck 1988)
The Beck Anxiety Inventory (BAI) is a self rating scale, and was
developed to address the need for an instrument thatwould reliably
discriminate anxiety from depression while displaying convergent
validity. The scale consists of 21 items, each describing a common
symptom of anxiety. Scoring is on a 4 point scale (0-3) and the
participant is asked to rate each symptom according to how much
they have been bothered by each symptom over the past week.
Ranges from 0 to 63. High score=poor.
b. Beck Depression Inventory BDI (Beck 1961)
The BDI is a self-administered 21 item self-report scale measuring
supposed manifestations of depression. The BDI takes approxi-
mately 10 minutes to complete, although clients require a fifth
sixth grade reading age to adequately understand the questions.
The highest score on each of the twenty-one questions is three; the
highest possible total for the whole test is sixty-three. The lowest
possible score for the whole test is zero. High score= poor.
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c. Beck Hopelessness Scale BHS (Beck 1974)
This 20-item self-report instrument assesses the degree to which
an individual holds negative expectations towards their future.
The underlying assumption is that hopelessness can be objectively
measured by defining it as a system of cognitive schemas with
a common denominator of negative expectations. High score =
poor.
d. Brief Psychiatric Rating Scale - BPRS (Overall 1962)
This scale is used to assess the severity of abnormal mental state.
The original scale has 16 items, but a revised 18-item scale is com-
monly used. Each item is defined on a seven-point scale varying
from ’not present’ to ’extremely severe’, scoring from 0-6 or 1-7.
Scores can range from 0-126, with high scores indicating more se-
vere symptoms. The BPRS-positive cluster comprises four items,
which are conceptual disorganisation, suspiciousness, hallucina-
tory behaviour and unusual thought content. The BPRS-nega-
tive cluster comprises only three items, which are emotional with-
drawal, motor retardation, and blunted affect.
e. Hamilton Depression Inventory - HAM-D (Hamilton 1960)
The HAM-D is a well-established 17-item scale for the measure-
ment of depression and is sensitive to change.
f. Hamilton Anxiety Rating Scale HARS (Hamilton 1959)
The Hamilton Anxiety Scale (HAMA) is a rating scale developed
to quantify the severity of anxiety symptoms. It consists of 14
items, each defined by a series of symptoms. Each item is rated on
a 5-point scale, ranging from 0 (not present) to 4 (severe). High
score = poor.
2.6.11.4 Behaviour
a. Beck scale for suicide ideation BSSI (Beck 1979)
The scale is made up of 21 items, with five screening items reduce
the length and the intrusiveness of the questionnaire for patients
who are non suicidal. The scale is a clinician-rating scale and is
presented in a semi structured interview format. After the inter-
view, the clinician assesses 19 items that evaluate three dimensions
of suicide ideation: active suicidal desire, specific plans for suicide,
and passive suicidal desire. Each item is rated on a 3-point scale
(i.e., 0 to 2). The total score is computed by adding each item
score. The range of possible scores is 0 to 38. High score = poor.
b. European Addiction Severity Index EuropASI (Kokkevi 1995)
The EuropASI is used for client clinical assessment and research
purposes. The EUROPASI can be used for different purposes in
assessing substance abuse clients: a) to assess the problem severity
of the interviewee, and b) for periodic repeated administrations
to monitor and quantify change in problems commonly associ-
ated to substance abuse. The EuropASI consists of 200 items in
6 subscales. Designed to address seven problem areas in substance
abusing patients; medical status; employment and support; drug
use; alcohol use; legal status; family/social status and psychiatric
status. Each of these dimensions include lifetime measures which
can serve as predictor variables, and past 30 day measures which
can serve as baseline/outcome measures. It also includes clinical
and patient reported ratings of problem severity in each problem
area.
c. Inventory of Interpersonal Problems Circumplex Version - IIP-
C (Alden 1990)
The Inventory of Interpersonal Problems (IIP) is a 127-item ques-
tionnaire that was composed from the most common complaints
of psychiatric patients at intake interviews. Alden 1990 created a
64-item version of the IIP with eight scales corresponding to the
eight octants of the Interpersonal Circle. The IIP-C is a 64-item
self-report instrument designed to measure interpersonal deficien-
cies and excesses. Items request that participants rate themselves
using a five-point response format (0 = not at all, 4 = extremely)
on phrases beginning “It is hard for me to.” or “I am too.” Exam-
ple items from the intrusive (NO) scale are “It is hard for me to
stay out of other people’s business,” and “I want to be noticed too
much.” High score = poor.
d. Longitudinal Interval Follow-up Evaluation - LIFE (Keller
1987)
LIFE is an integrated system for assessing the longitudinal course
of psychiatric disorders. It consists of a semi structured interview;
an instruction booklet, a coding sheet, and a set of training mate-
rials. An interviewer uses the LIFE to collect detailed psychosocial,
psychopathologic, and treatment information for a six-month fol-
low-up interval. The weekly psychopathology measures (’psychi-
atric status ratings’) are ordinal symptom-based scales with cate-
gories defined to match the levels of symptoms used in the Re-
search Diagnostic Criteria. The ratings provide a separate, con-
current record of the course of each disorder initially diagnosed
in patients or developing during the follow-up. Any DSM-III or
Research Diagnostic Criteria disorder can be rated with the LIFE,
and any length or number of follow-up intervals can be accommo-
dated. The psychosocial and treatment information is recorded so
that these data can be linked temporally to the psychiatric status
ratings. High score = poor.
e. Lifetime Parasuicide Count - LPC (Comtois 1999)
The Lifetime Parasuicide Count is a clinician-administered mea-
sure that obtains a lifetime overview of parasuicidal behaviour.
This measure provides brief information, including suicide intent
and medical severity, on the first incident, the most recent inci-
dent, and the most severe parasuicidal behaviour. This measure
also provides a chart of all methods and indicates the frequency of
parasuicidal behaviours by intent (suicide attempt, ambivalent sui-
cide attempt, non-suicidal self-injury) and highest medical sever-
ity (none, doctor visit, emergency room, medical unit admission,
intensive care admission).
f. Parasuicide History Interview - PHI (Linehan 1989)
The PHI is a 47-item semi structured interview measuring the to-
pography, intent,medical severity, social context, precipitating and
concurrent events, and outcomes for single parasuicide episodes.
The reasons for parasuicide can also be assessed during the PHI.
Specifically, participants are asked to review a 29-item list of po-
tential reasons and to indicate all that were reasons for their para-
suicide. These are collapsed into 29 distinct reasons, 22 of which
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were further clustered by expert consensus to form four rationally
derived scales: Emotion Relief (6 reasons), Interpersonal Influence
(8 reasons), Avoidance/Escape (5 reasons), and FeelingGeneration
(3 reasons). The remaining 7 reasons were each considered unique
and thus were not clustered.
g. Structured Clinical Interview for DSM-III-R for Axis II SCID-
II (Spitzer 1990)
There are three components to the SCID-II. The interview it-
self covers the 11 DSM-IV Personality Disorders (including Per-
sonality Disorder NOS) and the appendix categories Depressive
Personality Disorder and Passive-Aggressive Personality Disorder.
After the subject fills out the Personality Questionnaire (which
usually takes 20 minutes), the clinician simply circles the numbers
to the left of the SCID-II items that correspond to items answered
“yes” on the questionnaire. When the SCID-II is administered,
the clinician needs only to inquire about the items screened pos-
itive on the questionnaire. The assumption is that a subject who
responds with a “no” on the questionnaire item would also have
answered “no” to the same question had it been read aloud by the
interviewer. High score = poor.
h. Social Adjustment Scale-Interview - SAS-I (Weissman 1971)
Measures social functioning in a number of life domains (work,
social, extended family, marital, parental, family unit, and eco-
nomic adequacy) on a scale of 1-7. High score = poor
i. Social Adjustment Scale-Interview - Self report - SAS-SR (
Weissman 1976)
The Social Adjustment Scale Self-Report (SAS-SR) is a 42-item
self-report questionnaire that measures affective or instrumental
performance over the past 2 weeks in seven major areas of social
functioning: work (as a worker, housewife or student), social and
leisure activities, relationship with extended family, marital role
as a spouse, parental role, membership in the family unit, and
economic adequacy.
j. Symptoms Check List - SCL90-R (Derogatis 1977)
The Symptoms Check List is a self-rated instrument containing
90 symptom related questions. The subject assesses the degree of
severity of each symptom: The scale ranges from: 0 (’Not at all’) 1
(’A little bit’) 2 (’Moderately’) 3 (’Quite a bit’) to 4 (’Extremely’).
High score=poor.
k. Spielberger State and Trait Inventory - STAI (Spielberger 1970)
This inventory measures adult anxiety as an emotional state, i.e.
the anxiety that a person experiences under certain given condi-
tions, and personality trait, i.e. a relatively enduring personality
characteristic that reflects the individual’s propensity to respond
with anxiety to a broad range of conditions. The STAI is a 20 items
scale. The STAI scores increase in response to stress and decrease
under relaxing conditions. High score = poor.
l. Spielberger Anger Expression Scale STAXI (Spielberger 1985)
The STAXI can be used to assess anger components in detailed
evaluations of normal and abnormal personality. The STAXI is a
20-item measure, with fifty seven items measuring the intensity
of anger as an emotional state and the disposition to experience
angry feelings as a personality trait. Scales include: State Anger,
Trait Anger, Anger Expression-Out, Anger Expression In, Anger
Control-Out, Anger Control-In and Anger Expression Index. All
items are scored on a 4-point scale ranging from 1 (almost never)
to 4 (almost always). The STAXI asks about frequency of feeling
quick tempered, hot-headed, and flying off the handle. High score
= poor.
Risk of bias in included studies
1. Randomisation
All reports stated that the studies were randomised. Turner 2000
did not describe the process at all. In Bateman 1999, however,
details were obtained from the author who was able to report that
randomisation was performed off site and undertaken using com-
puter generated randomisation tables. Koons 2001 also provided
further details. Randomisation was undertaken by the research of-
fice at the VA Medical Centre, using the computers to generate
a random number table from which allocation was worked out.
Linehan 1991 matched people entering the study to the number
of lifetime parasuicides psychiatric hospitalisations, age and prog-
nosis. We have no further details of the methods used to allocate
participants. In Linehan 1999 a minimisation method was used,
with similar matching undertaken on four variables of severity of
drug dependence, presence or absence of present cocaine abuse,
the presence of antisocial personality disorder and a global assess-
ment of functioning. Linehan 2002 used the same procedure. van
den Bosch 2002 reports using minimisation to match on age and
severity of suicidal behaviour and substance misuse, with no de-
tails of how allocation was performed after matching.
2. Blinding
Bateman 1999 andKoons 2001 do notmention blinding. Linehan
1991, Linehan 1999 and Linehan 2002 all used independent clin-
ical interviewers, blinded to allocation but no testing of these rates
is reported. Turner 2000 also used blinded independent rater eval-
uations who were unaware of treatment condition but aware of
study purpose. van den Bosch 2002 used independent clinicians
blinded to the study, but they are unlikely to be blind to the con-
ditions.
3. Follow-up
In comparison with drug trials, length of follow-up is long and
loss to follow-up low. van den Bosch 2002 is included for the
outcome of leaving the study early and self mutilating behaviour
in the previous six months. This study did have high levels of
dropout (37% DBT group vs 77% of treatment as usual group).
However, the majority of participants were followed up for the
52 weeks duration of the study (~74%). In Turner 2000, whilst
four people left the DBT group (one returned after a five week
break), and six from theCCT group, all participants were followed
up at 12 months. In Linehan 1991, a third of those who began
the study were left out of the final analysis by the trialists. In
Linehan 1999, it is unclear whether the last observation carried
15Psychological therapies for people with borderline personality disorder (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
forward technique was used or participants were actually followed
up. Attempts to contact the trialists for further information have
been unsuccessful.
4. Outcomes
In the studies, the reporting of the data was not good and much
data were lost to this review.
5. Overall
The overall reporting of methods within the seven studies was
not good and leaves all results at moderate risk of bias (Cochrane
Category B, Clarke 2002).
Effects of interventions
1. COMPARISON 1. DIALECTICAL BEHAVIOUR THER-
APY versus TREATMENT AS USUAL
Three studies were included in this comparison with high dropout
(van den Bosch 2002) and differing duration (Koons 2001 - 6
months; Linehan 1991 - 12 months).
1.1 General
Koons 2001 found no statistical difference between people in the
DBT group and those in the treatment as usual group for the
outcome of still meeting SCID-II criteria for the diagnosis of BPD
by six months in this small study (n=28, RR 0.69 CI 0.35 to 1.38).
Koons 2001 also reported skewed equivocal data for the outcome
of average number of SCID-II BPD criteria by six months in
Koons 2001 (n=20).
1.2 Service outcomes
Koons 2001 found no difference between groups for admission to
hospital in the previous three months (n=28, RR 0.77 CI 0.28 to
2.14).
1.3 Behaviour
For self-harm Koons 2001 did not find any statistical difference
betweenpeople receivingDBTand treatment as usual by 6months
(n=28, RR number of people undertaking self harm or parasui-
cide 0.66 CI 0.25 to 1.75). However, Linehan 1991 does report a
small significant difference at 6 to 12 months (n=63, RR 0.81 CI
0.66 to 0.98, NNT 12 CI 7 to 108). For the outcome of display-
ing self mutilating behaviour in the previous six months, van den
Bosch 2002 did not find any difference between groups (n=64,
RR self mutilating behaviour 0.69 CI 0.45 to 1.06). Koons 2001
and Linehan 1991 both report skewed data for the average num-
ber of parasuicidal acts at 6 months, and Linehan 1991 at 6 to
24 months but their findings were not conclusive. Linehan 1991
(n=35)provides skewed data for the average risk scores for parasui-
cide episodes by 6 to 12 months that favour the DBT and again
reports skewed data, over three time periods of 6 to 12 months,
12 to 18 months and 18 to 24 months for the average number of
medically treated parasuicide episodes. Again these figures tend to
favour DBT.
1.4 Mental state
No difference was found in the small study undertaken by Koons
2001 for ’anger - in’ using the STAXI (n=28, RR no clinically
significant change 0.64 CI 0.29 to 1.43) or ’anger - out’, again
using the STAXI (RR 0.64 CI 0.29 to 1.43); depression using
the BDI (RR 0.62 CI 0. 36 to 1.07); dissociation using the DES
(RR 0.52 CI 0.25 to 1.11); and suicidal ideation using the BSSI
(RR 0.62 CI 0.36 to 1.07). A slight difference was found in levels
of hopelessness, with those on DBT reporting less hopelessness,
using the BHS (RR 0.53 CI 0.29 to 0.99, NNT 3 CI 2 to 116).
Reporting endpoint continuous results using the STAXI for ’anger
- in’ and ’anger - out’, Koons 2001 did not detect differences
(n=20, MD ’anger - in’ -1.90 CI -6.47 to 2.67, RR anger -out MD
-3.40 CI -7.89 to 1.09). Using the HARS, Koons 2001 detected a
statistical difference for the outcome of anxiety scores at 6 months
for people receivingDBTcomparedwith treatment as usual (n=20,
MD average anxiety scores -13.10 CI -22.08 to -4.12). For the
outcome of depression Koons 2001 detected a statistical difference
in favour of those receiving DBT than those TAU at six months,
measured using the HAM-D and reporting continuous end point
data (n=20,MD -7.20 CI -13.19 to -1.21) and also reports skewed
results for average depression scores using the BDI. The latter tend
to favour the DBT but it is unclear if the results are statistically
significant.
The dissociation average score by 6 months reported by Koons
2001 are skewed and did not clearly favour wither treatment.
Koons 2001s average hopelessness score were also skewed although
these did tend to favour the DBT group. Koons 2001 detected
statistical difference in favour of people receiving DBT compared
with those allocated to treatment as usual for average scores of
suicidal ideation at 6 months (n=20, MD -15.30 CI -25.46 to -
5.14).
1.5 Leaving the study early
All three studies combined found no difference for the outcome
of leaving the study early, with 29/76 in the DBT group leaving
early and 41/79 in the TAU group (n=155, 3 RCTs, RR leaving
the study early 0.74 CI 0.52 to 1.04).
1.6 Substance use
van den Bosch 2002 reports data for alcohol use (average days >4
drinks past month; average days alcohol problems past month;
and average severity of alcohol problems) and drug use (average
days drug problems pastmonth; average severity of drug problems;
and average days medication use in the past months). All data are
skewed and do not convincingly favour either treatment.
2. COMPARISON 2. DIALECTICAL BEHAVIOUR THER-
APY - SUBSTANCE USE versus TREATMENT AS USUAL
2.1 Death: sudden / unexpected
Linehan 1999 reports one person dying in the DBT group. This
does not reach conventional levels of statistical significance (n=28,
RR 3.92 CI 0.17 to 88.67).
2.2 Leaving the study early
Linehan 1999 did not detect a significant difference between peo-
ple with substance abuse problems receiving DBT (5/12) leaving
the study early compared with those with substance abuse prob-
lems receiving treatment as usual (5/16) (n=28, RR 1.33 CI 0.50
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to 3.58).
2.3 Substance use
For the outcome of interviewer-assessed alcohol free days, skewed
data are reported and tend to favour DBT. Linehan 1999 reports
skewed but not statistically significant data for the proportion of
participants with a clean urinalyses test.
3. COMPARISON 3. DIALECTICAL BEHAVIOUR THER-
APY - SUBSTANCE USE versus COMPREHENSIVE VALI-
DATION THERAPY PLUS 12-STEP
3.1 Service outcomes
For the number of nights in prison Linehan 2002 found no dif-
ference between those receiving DBT and those comprehensive
validation therapy plus 12-step (n=23, RR 1.09 CI 0.64 to 1.87).
Linehan 2002 also reports non-significant skewed data for the av-
erage number of nights in prison at 12 to 18 months follow up.
3.2 Leaving the study early
Conventional levels of statistical significance were not achieved
between groups for the outcome of leaving the study early (n=23,
RR 7.58 CI 0.44 to 132.08).
4. COMPARISON 4. DIALECTICAL BEHAVIOUR THER-
APY-ORIENTED TREATMENT versus CLIENT CENTRED
THERAPY
4.1 Service outcomes
Turner 2000 found no statistical difference between people receiv-
ing DBT and those allocated to client centred therapy (CCT) for
the outcome of being admitted to hospital (n=24, RR 0.33 CI
0.08 to 1.33).
4.2 Behaviour
Turner 2000 also recorded self harm / parasuicide behavioural
indicators. Fewer people in the DBT orientated therapy group
displayed indicators of parasuicidal behaviour (n=24, RR 0.13 CI
0.02 to 0.85, NNT 2 CI 2 to 11).
4.3 Mental state
In the follow up phase of Turner 2000 this group found no differ-
ences for outcomes of anxiety and depression (n=24, RR anxiety
BAI >/=10 0.60 CI 0.32 to 1.12; RR depression HDRS >/=10
0.43 CI 0.14 to 1.28). However, using the BDI to measure de-
pression these researchers found a statistically significant differ-
ence (n=24, RR no clinically significant change - BDI >/=10 0.50
CI 0.28 to 0.88, NNT 3 CI 2 to 9); those on DBT had less de-
pression than people allocated to CCT. Also, Turner 2000 found
a statistically significant difference in general psychiatric severity
(n=24, RR BPRS >/=15 0.58 CI 0.36 to 0.94, NNT 3 CI 2 to
17). People allocated to DBT also displayed less suicidal ideation
(n=24, RR BSSI score >3 0.13 CI 0.02 to 0.85, NNT 2 CI 2 to
11).
Continuous results of the BAI for anxiety (n=24, RR -4.50 CI
-8.80 to -0.20), show people allocated to DBT had less anxiety
than those on Client Centred Therapy, and also displayed less
depression when measured using the BDI (n=24, RR -6.67 CI -
11.95 to -1.39). Turner 2000 reports skewed results for anxiety or
depression at six months, and in the follow up of 6 to 12 months
but both sets of data suggest a more favourable outcome for those
allocated toDBT.Turner 2000 also reports skewed data for anxiety
(BAI) and depression (BDI) at 6 to 12 months follow up. These
data tend to favour DBT.
People in Turner 2000 who received DBT had less general psychi-
atric severity than those in the control, reported by continuous re-
sults from the BPRS at 6 months (MD -7.41 CI -13.72 to -1.10).
This was also true at follow up by 6 to 12 months (n=24, MD
-7.16 CI -12.15 to -2.17). Finally Turner 2000 reports skewed
data for suicidal ideation with considerably lower scores for people
allocated to DBT.
4.4 Leaving the study early
Turner 2000 found no difference between groups for leaving the
study early (n=28, RR 0.67 CI 0.25 to 1.78).
5. COMPARISON 5. PSYCHOANALYTICALLY ORIENTED
PARTIAL HOSPITALIZATION versus GENERAL PSYCHI-
ATRIC CARE
5.1 Service outcome
In Bateman 1999, those who received treatment in a psychoana-
lytic orientated day hospital were less likely to be admitted into in-
patient care than people in general psychiatric care in the previous
six months when measured at three different time points (n=44,
RR admitted to inpatient 24 hour care >18 to 24 months 0.05
CI 0.00 to 0.77, NNT 3 CI 3 to 10; >24 to 30 months RR 0.10
CI 0.01 to 0.72, NNT 3 CI 3 to 8; >30 to 36 months RR 0.06
CI 0.01 to 0.40, NNT 2 CI 2 to 3). Bateman 1999 also reports
data for the average number of days spent in hospital. These are
skewed and are reported in the ’other data’ tables. All considerably
favour the psychoanalytic orientated day hospital care package.
Onone from the partial hospitalisation groupneeded re-admission
to the day hospital programme at >18 to 24 months, whereas 13
of those in the general psychiatric care group needed some form of
day hospital intervention. This was statistically significant (n=44,
1 RCT, RR of needing day hospital intervention in the 18 months
after discharge 0.04 CI 0.00 to 0.59, NNT 2 CI 2 to 8). This
was also statistically significant at >24 to 30 months (RR 0.05
CI 0.00 to 0.77, NNT 3 CI 3 to 10). The skewed data for the
average number of days partially hospitalised is presented and also
significantly favours the psychoanalytic orientated day hospital.
There are similar findings for average number of days attending
community centre (skewed data).
More people in the control group in Bateman 1999 took psy-
chotropicmedication by the 30 to 36month follow-up, than those
receiving psychoanalytic treatment (n=44, RR of receiving a psy-
chotropic medication 0.44 CI 0.25 to 0.80, NNT 3 CI 2 to 7).
This one study reports the number of people receiving more than
one psychotropic medication at 30 to 36 month follow-up. The
control group (16/22) were more likely to receive more than one
drug (3/22) (n=44, RR of being on more than one psychotropic
drug at 30 to 36 months 0.19 CI 0.06 to 0.55, NNT 2 CI 2 to
4).
5.2 Mental state
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Bateman 1999, measuring anxiety using the STAI, did not find
any difference between intervention group and control for the
outcome of anxiety state by six months (MD 0.40 CI -6.49 to
7.29). However, at all other time points, up to three years, people
receiving psychoanalytic therapy reported less anxiety than those
in general psychiatric care (by 6 to 12 months, n=38, MD -9.00
CI -15.01 to -2.99; by 12 to 18 months, n=38, MD -13.00 CI -
19.65 to -6.35; by 18 to 24 months follow up, n=36, MD -9.70
CI -16.42 to -2.98; by 24 to 30 month follow up, n=36, MD -
14.40 CI -21.74 to -7.06; by 30 to 36 month follow up, n=33,
MD -19.80 CI -25.81 to -13.79). However for anxiety trait, again
using the STAI, at no other time point other than the 30 to 36
months, was a statistically significant finding found (within six
months MD -0.20 CI -5.19 to 4.79; by 6 to 12 months MD -
0.20 CI -4.78 to 4.38; by 12 to 18 months MD -4.20 CI -9.53 to
1.13; by 18 to 24 months follow up MD -2.10 CI -8.25 to 4.05;
by 24 to 30 month follow upMD -3.40 CI -9.87 to 3.07). Figures
for 30 to 36 month follow up demonstrate a difference in anxiety
trait favouring people receiving partial hospitalization (MD -8.30
CI -14.01 to -2.59).
For depression, measured using the BDI, at 12 to 18 months and
18 to 24 months, there is no clear difference between those in the
experimental and control group (n=44, 1RCT,RR0.86CI 0.73 to
1.02; and 18 to 24 months RR 0.76 CI 0.58 to 1.00). At 24 to 30
months and 30 to 36months, however, those in the psychoanalytic
orientated day hospital report less depression (n=44, 1 RCT, RR
>/=14 on BDI 0.52 CI 0.34 to 0.80, NNT 3 CI 3 to 6; 30 to 36
months, RR 0.45 CI 0.27 to 0.76, NNT 3 CI 3 to 5). For the
outcome of depression, reported using continuous data from the
BDI, Bateman 1999 found no difference in the first six months
(within sixmonthsMD -0.20 CI -6.25 to 5.85). However, at every
time point thereafter, people receiving psychoanalytic day hospital
care showed lower levels of depression than those in the general
psychiatric care (by 6 to 12 months MD -8.00 CI -13.66 to -
2.340; by 12 to 18 months MD -14.60 CI -19.18 to -10.02; by
18 to 24 months follow up MD -9.70 CI -14.47 to -4.93; by 24
to 30 month follow up MD -8.20 CI 12.85 to 3.55; by 30 to 36
month follow up MD -8.50 CI -13.83 to -3.17).
For the outcome of global severity Bateman 1999 scored using
the SCL-90-R. This study found no significant difference between
groups at all time points apart from the 18 to 24months (within six
months MD 0.00 CI -0.38 to 0.38; by 6 to 12 months MD -0.20
CI -0.61 to 0.21; by 12 to 18monthsMD -0.30 CI -0.78 to 0.18).
At the 18 to 24 months follow up, the MD was -0.70 CI -1.13
to -0.27). Finally there are some skewed data at 24 to 30 months
and at 30 to 36 month (SCL-90-R). Positive symptoms, scored
on this same scale are not statistically significant at six months,
12 months and by 18 months (six months MD 3.20 CI -4.44 to
10.84; by 6 to 12 months MD 3.10 CI -6.64 to 12.84 and by 12
to 18 months MD -2.40 CI -12.70 to 7.90). However, by 18 to
24 months follow up there is a finding statistically significantly in
favour of people receiving psychoanalytic day hospital care (MD
-12.70 CI -22.18 to -3.22). By 24 to 30 month follow up, the
finding remains significant (n=44, 1 RCT, MD -24.10 CI -34.13
to -14.07), as it does for the 30 to 36 month follow up (MD -
33.90 CI -43.59 to -24.21).
5.3 Quality of life
Bateman 1999 reports that people receiving psychoanalytic care in
a day hospital had better social improvement in social adjustment
using the SAS-SR at 6 to 12 months compared with people in
general psychiatric care (MD -0.70 CI -1.08 to -0.32). This also
applied to the 30 to 36 month follow up (MD -1.30 CI -1.68
to -0.92). At 12 to 18 months, Bateman 1999 reports statistically
significant results in favour of people in the experimental group
for the outcome of fewer interpersonal problems (MD -0.70 CI
-0.89 to -0.51). This too applied at 30 to 36 month follow up
(MD -1.00 CI -1.28 to -0.72).
5.4 Leaving the study early
There was no difference for leaving the study early from either
the experimental group or those in the control. Only three people
from each arm left (n=44, 1 RCT, RR 1.00 CI 0.23 to 4.42).
D I S C U S S I O N
1. Limitation of data
Despite a comprehensive search for randomised controlled trials
for psychological therapies for people with BPD, and the increas-
ing prevalence of this approach, this review has only been able to
find seven, small studies of moderate quality. This is similar to
other reviews. It is possible that we have failed to identify relevant
work. We would be grateful for any contact from anyone with
knowledge of any relevant trials. This is a difficult area of research
but the production of these seven studies does demonstrate that
relevant evaluative research is feasible.
The small numbers of included participants in this review make
type 1 errors more possible, as well as multiple testing ,using a
variety of scales makes it probable that only positive findings are
reported in reports of studies, whilst statistically insignificant, or
neagtive results, do not get reported, leading to reporting bias.
Data were lost because of unclear reporting. Should the studies
we identified have reported as clearly as is now expected after the
CONSORT guidelines (Moher 2001) considerably more might
have been known on the effects of treatment of people with a
borderline personality disorder.
The use of scales may be of value for generating or investigating
hypotheses but they are often of little clinical utility. Binary out-
comes such as ’improved or not’, ’self harm or not’ should be pos-
sible to collect in this field. In scale data carrying the last obser-
vation forward is not altogether useful as this generates such large
assumptions about the data that often findings are not sensible to
include. Pioneering studies such as van den Bosch 2002, however,
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illustrate that following people up after leaving the study early is
possible and informative.
2. Applicability
Participants in the included studies were recognisable to most peo-
ple working in this field and the interventions potentially acces-
sible to a well-funded health service provider. Outcomes such as
admission to hospital and abstinence from drugs are also clinically
important. The difficulty in interpretation of some of the scale-
derived results, however, does limit clinical utility.
Also, the two main professionals in this field are two of the ma-
jor contributors of studies to this review (Linehan 1991; Linehan
1999; Linehan 2002; Bateman 1999). What effect the presence of
these two leaders has, does need to be questioned, especially with
such small numbers and such positive responses in the experimen-
tal groups.
Finally, studies were undertaken in North America (Koons 2001;
Linehan 1991; Linehan 1999; Linehan 2002; Turner 2000) and
Europe (Bateman 1999; van den Bosch 2002) and how applicable
any findings are to other services has to be a matter of conjecture.
3. COMPARISON 1. DIALECTICAL BEHAVIOUR THER-
APY versus TREATMENT AS USUAL
There are few data which could be combined, but the three studies
demonstrate that research and follow up of this group of people is
possible.
3.1 Global
The finding that there was no clear effect of DBT for a proxy
measure of improvement (not meeting SCID-II criteria for BPD
at six months) in the one under-powered study (n=28) does not
prove that DBT is unhelpful.
3.2 Service outcomes
The DBT group did have a reduction in admission by a consid-
erable degree (n=28, RR 0.77 CI 0.28 to 2.14) and this finding
could be very important if replicated and strengthened.
3.3 Behaviour
DBT does seem to offer a small benefit over treatment as usual
in preventing people undertaking acts of self-harm or parasucide.
This is a consistent finding although it is not always statistically
significant in the small trials. In the one larger study (n=63) the
finding did reach conventional levels of statistical significance at
12 months with a number needed to treat that may be considered
feasible (NNT 12 CI 7 to 108).
3.4 Mental state
For those who receive DBT there may be a benefit. There was less
hopelessness (NNT 3 CI 2 to 116) in Koons 2001 (n=28) but no
clear benefit in terms of anger, either inward or outward looking
in over a 6 to 24 month period. People receiving DBT also report
less anxiety at 6 months and less suicidal ideation (n=20, MD -
15.30 CI -25.46 to -5.14) but although this last finding could be
important we are unclear how to interpret the continuous measure
in clinically meaningful terms.
3.5 Leaving the study early
DBT may help keep people in care (n=155, 3 RCTs, RR leaving
the study early 0.74 CI 0.52 to 1.04) and it does not seem to put
people off continuing in treatment.
3.6 Substance use
The van den Bosch 2002 data are not convincing that DBT has
any effect on alcohol use.
4. COMPARISON 2. DIALECTICAL BEHAVIOUR THER-
APY - SUBSTANCE USE versus TREATMENT AS USUAL
4.1 Death
One person died in one small study (Linehan 1999, n=28). Of
course this rare outcome is important to record and it is likely a
sad chance finding (RR 3.92 CI 0.17 to 88.67) but highlights that
the talking therapies, just like any other, may have adverse effects
that go unrecorded or unreported.
4.2 Leaving the study early
Again, DBT seems no better, and no worse than treatment as usual
for holding on to people in trials. About 30% of study participants
left early (n=28).
4.3 Substance use
When the DBT is particularly focused on substance misuse and
the participants reflect this bias the treatment does not have con-
vincing effects on behaviour.
5. COMPARISON 3. DIALECTICAL BEHAVIOUR THER-
APY - SUBSTANCE USE versus COMPREHENSIVE VALI-
DATION THERAPY PLUS 12-STEP
5.1 Service outcomes.
DBT does not seem to prevent any more people spending the
night in prison than comprehensive validation therapy and 12 step
programs but the study was too small to be convincing (n=23,
1 RCT, RR 1.09 CI 0.64 to 1.87). It was, however, good to see
a study proving trials in this setting are possible and potentially
informative.
5.2 Leaving the study early
Again the equivocal findings are impossible to interpret as the one
trial was so small (n=23).
6. COMPARISON 4. DIALECTICAL BEHAVIOUR THER-
APY-ORIENTED TREATMENT versus CLIENT CENTRED
THERAPY
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This comparison contains only Turner 2000 (n=24).
6.1 Service outcomes
DBT may considerably reduce admission compared with client
centred therapy (RR0.33CI0.08 to 1.33) but confidence intervals
are too wide to draw firm conclusions. This finding could be very
important but needs replicated.
6.2 Behaviour
Fewer people who receive DBT orientated therapy display fewer
indicators of parasuicidal behaviour (NNT 2 CI 2 to 11). This
too is an important finding needing replicated in a larger, longer
study.
6.3 Mental state
When anxiety or depression is measured using one measure
(HDRS) DBT seems to have no effect. When the BDI is the mea-
sure there seems an effect on depression favouring DBT (NNT
3 CI 2 to 9) with similar findings for the BAI for anxiety. Also
those allocated to DBT had less general psychopathology (NNT
3 CI 2 to 17) and less suicidal ideation (NNT 2 CI 2 to 11). If
some of these latter results are replicated these could represent very
important findings of great practical value.
6.4 Leaving the study early
DBT does not seem off-putting but the study was too small and
too under-powered to be sure of this (n=28, RR 0.67 CI 0.25 to
1.78).
7. COMPARISON 5. PSYCHOANALYTICALLY ORIENTED
PARTIAL HOSPITALIZATION versus GENERAL PSYCHI-
ATRIC CARE
All findings are from Bateman 1999 (n=44).
7.1 Service outcome
Those who receive treatment in a psychoanalytic orientated day
hospital are less likely to be admitted into inpatient care than
people in general psychiatric care by six months. This is also true at
18 to 24months (NNT3CI 3 to 10), 24 to 30months (NNT3CI
3 to 8) and at 30 to 36 months (NNT 2 CI 2 to 3). The NNTs are
very small and if this finding would hold across other studies this
could be most important. As it stands it is interesting, hypothesis
generating, but not conclusive. One swallow does not a summer
make. Also, in this one study, people receiving psychoanalytic care
had less re-admission at 18 to 24 months compared with those in
general psychiatric care. This also holds for the 18 month (NNT 2
CI 2 to 8) and 24 to 30 month follow up (NNT 3CI 3 to 10). Less
surprisingly, people in psychoanalytic orientated day hospital were
given less medication than those in general psychiatric care (NNT
3 CI 2 to 7) and were also less likely to receive polypharmacy at
30 to 36 months (NNT 2 CI 2 to 4).
All these findings are most important, clinically meaningful, and
if the NNTs hold true, feasible within many health service. The
problem remains that this is one study undertaken by an enthu-
siastic team and should be replicated. Of course, mental health
services have reacted to such limited but positive evidence in the
past with mixed results (Pharoah 2003; Marshall 2000b; Marshall
2004).
7.2 Mental state
At six months people who receive treatment in psychoanalytic day
hospital care are as likely to have symptoms of an anxiety state
as those in general psychiatric care. However, at all other time
points, those receiving psychoanalytic therapy are less likely to be
as anxious. People who receive psychoanalytic day hospital care
may also expect to have lower levels of depression compared with
those in general psychiatric care (30 to 36 months, NNT 3CI 3 to
5). The SCL-90-R data on global severity and positive symptoms
are less certain. Again, overall the impression is positive for the
psychoanalytic day hospital care and well worthy of replication.
7.3 Quality of life
For those in psychoanalytic day care can expect improvement in
social adjustment at 6 to 12 months, and at 30 to 36month follow
up and fewer interpersonal problems at 12 to 18months, and at 30
to 36 months. We, however, find it difficult to determine whether
a decline of 0.7 in the SAS-SR as a measure of social improvement,
or a declind of 1.0 on the samemeasure for interpersonal problems
is really clinically meaningful.
7.4 Leaving the study early
Psychoanalytic day care does not seem any better, or worse, at
keepingpeople involvedwith therapy than general psychiatric care,
although it is remarkable how little attrition there is compared to
drug trials (14% by 36 months). We look forward to more data as
trialists are now analyzing four-year follow up data.
8. Missing outcomes
Studies in this area are difficult and long term follow up necessary.
It would be good to seem some economic analyses of these inter-
ventions and measures of potential adverse effects.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
1. For people with borderline personality disorder
This review suggests that some of the problems frequently en-
countered by people with borderline personality disorder may be
amenable to talking/behavioural treatments. Several of the studies
showed that the effort invested by the recipient of care in stick-
ing with the care package was rewarded by a decline in anxiety,
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depression, self harm, hospital admission and use of prescribed
medication. All these therapies remain experimental and the stud-
ies are too few and small to have full confidence in their results.
People with borderline personality disorder, if offered entry into
a randomised study of therapies may wish to consider that the
outcomes of both experimental and control groups are probably
going to be better than those of the standard care outside of the
trial.
2. For clinicians
This review has much good news for the clinician. People with
borderline personality disorder may be considered unrewarding to
treat. This synthesis suggests that the talking therapies, if avail-
able, may have considerable positive effects. Even if the findings
are not applicable outside the small studies, often undertaken by
enthusiastic pioneers in the field, they may indicate that people
with borderline personality disorder are amenable to change. All
treatment is not without hope.
3. For policy makers and funders of research
Many findings in this review are, potentially,most important, clin-
icallymeaningful. Small numbers needed to treatmake implemen-
tation feasible within many health services. Several times in the
past mental health services have reacted to such limited but posi-
tive evidence with mixed results (Pharoah 2003; Marshall 2000b;
Marshall 2004). These findings should be replicated in larger real-
world studies.
Implications for research
1. General
Of all the included studies only Linehan 1991 preceded the rec-
ommendations of the CONSORT statement (Begg 1996, Moher
2001). If the recommendations had been followed more data
would have been available from the trials already identified. In-
cluded trials often failed to reassure the readers that inclusion of
bias was minimised at allocation and well-described and tested
blinding could have encouraged confidence in the control of per-
formance and detection bias.
2. Specific
These studies do report many clinically meaningful outcomes but
there is still the opportunity at the design stage to cut out redun-
dant effort in recording data from scales that have never been val-
idated. Even if the scales have been validated on this population
clinical interpretation of the results would be a most useful addi-
tion to the reports.
This review shows that long trials are possible and reports many
data that are positive and hypothesis generating. This would seem
like a fruitful area for more studies that are large, long and collab-
orative; participants are common and different interventions are
all experimental. Meaningful outcomes can be recorded in every-
day follow up notes. The approaches already studied could well
be both clinically effective and cost effective.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Bateman 1999
Methods Allocation: randomised using a computer away from treatment site.
Blinding: none.
Duration: maximum 18 months treatment (average 1.45 years) + 18-month follow-up.
Setting: outpatient.
Participants Diagnosis: borderline personality disorder (SCID-II, DIB).
N=44.
Sex: 22/38 completers were women (58%).
Age: mean ~32 (SD ~6).
Exclusion criteria: DSM-III-R schizophrenia, bipolar disorer substance misuse, mental impairment or
evidence of organic brain disorder. Comorbid Axis I diagnoses included major depression, dysthmia, panic
disorder, agoraphobia, sociophobia and bulimia.
Interventions 1. Psychoanalytically oriented partial hospitalization: over five days, once-weekly individual psychoanalytic
psychotherapy, thrice-weekly group analytic psychotherapy (1 hour each), once-a week expressive therapy
orinted towards psychodrmama techniques (1 hour), weekly community meeting (1 hour). Once amonth:
meeting with case administrator (1 hour) and medication review (antidepressants and antipsychotics as
required). Treatment integrity monitored. N=22.
2. General psychiatric care: regular psychiatric review with senior psychiatrist (average twice per month),
inpatient admission if required (90% with average stay of 11.6 days), and discharge to nonpsychoanalytic
psychiatric partial hospitalisation focused on problem solving (72% for an average of 6 months), and out-
patient/community follow-up as standard aftercare (100%, twice weekly visits by Community Psychiatric
Nurse). Received no formal psychotherapy. N=22.
Outcomes Leaving the study early: treatment drop out and lost to follow-up.
Mental state: BDI, SCL90-R, STAI.
Quality of life: interpersonal problems - IIP-CV, social adjustment - SAS-SR.
Service outcomes: psychiatric service utilisation, psychotropic medication use at follow-up.
Unable to use -
Service outcomes: hospital admissions (no data reported), length of inpatient admissions (data only
reported in diagramatic form), taking psychotropic medication (only percentages reported).
Behaviour: suicide attempts and self-mutilating behaviour - SSHI (semi-structured interview not validated
or published in peer reviewed journal).
Notes People who crossed over to the partially hospitalised group if the psychiatrist deemed it necessary were
classed as leaving the study early.
* some missing data. Reviewers assume poor outcome for these people.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
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Koons 2001
Methods Allocation: randomised, unrestricted, computerised random number generation.
Blinding: blind assessment interviewers.
Duration: 6 months.
Setting: outpatient.
Participants Diagnosis: borderline personality disorder (SCID-II).
N=28.
Sex: women.
Age: mean ~35 years (SD~8), N=20.
History: no current diagnosis for schizophrenia, bipolar disorder, substance dependence or antisocial
personality disorder.
Interventions 1. Dialectical behaviour therapy: individual therapy (prioritised hierarchy of target behaviours, telephone
coaching with individual therapists between sessions) + groups skills training: 90mins / week for 6months.
N=13.*
2. Treatment as usual: offered 60 mins / week individual therapy, supportive and psychoeducational
groups. 6 months treatment. N=15.
Outcomes Still meeting criteria for BPD: SCID-II.
Service outcomes: admissions - THI.
Behaviour: parasuicidal acts - PHI.
Mental state: BDI, BHS, BSSI, DES, HAM-D, HARS, STAXI.
Number of BPD criteria met: SCID-II.
Leaving the study early.
Notes * Reports only completer data (n=20, 10 / group). Reviewers assume poor outcome for people who did
not complete.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes A - Adequate
Linehan 1991
Methods Allocation: matched on number of lifetime parasuicides and psychiatric hospitalisations, age and good vs
poor clinical prognosis and randomly assigned to treatment condition.
Blinding: research assessors blind to treatment condition.
Duration: 1 year treatment + 1 year follow-up.
Setting: outpatient.
Participants Diagnosis: borderline personality disorder (DIB and DSM-III criteria).
N=63.
Sex: women.
Age: 18-45 years.
History: at least 2 incidents of parasuicide in the last five years (1 in last 8 weeks), did not meet DSM-III
criteria for schizophrenia, bipolar disorder, substance dependence or mental retardation.
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Linehan 1991 (Continued)
Interventions 1. Dialectical behaviour therapy: weekly individual (1 hour, behavioural skill training, contingency man-
agement, cognitive modification, exposure to emotional cues, reflection, empathy, acceptance)and group
therapy (2.5 hours, psychoeducational, teaching behavioural skills) for one year. N=32.
2. Treatment as usual: alternativetherapy referrals, via referring agency. 73% began individual therapy.
N=31.
Outcomes Behaviour: parasuicidal acts and severity: PHI.
Leaving the study early.
Service outcomes: admissions,THI.
Mental state: STAS-T (trait portion only).
Quality of Life: social adjustment at follow-up: SAS-I, SAS-SR LIFE (provides GAS score)
Unable to use -
Mental state: BDI, SSI, BHS, RLISC (data not reported).
Influence of therapist characteristics: TI (not a protocol outcome, no data reported, subset of original
sample).
Quality of life: social adjustment during treatment GAS, LIFE, SAS-SR (subsample of original sample).
Mental state: anger: STAS-T (subsample of original study data).
Notes * Reports only completer data. Reviewers assume poor outcome for people who did not complete.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Linehan 1999
Methods Allocation:minimisation randomisation (matched on age, severity of drugdependence, readiness to change
and global adjustment).
Blinding: independent clinical interviewers.
Duration: 1 year treatment + 4 months follow-up.
Setting: outpatient.
Participants Diagnosis: borderline personality disorder (SCID-II and PDE).
N=28.
Sex: women.
Age: mean ~30 years (SD 7).
History: also met criteria for substance use disorderfor opiates, cocaine, amphetamines, sedatives, hyp-
notics, anxiolytics, or polysubstance use disorder on SCID-II; 12% of sample diagnosed with antisocial
personality disorder; and excluded if met criteria for schizophrenia, another psychotic disorder, bipolar
mood disorder or mental retardation. 19/24 taking psychotropic medication at beginning of study.
Interventions 1. Dialectical behaviour therapy: core elements of standard manualised DBTmodified for substance abus-
ing population, weekly individual psychotherapy (1hour), groups skills training (2hours 15mins), skills
coaching phone calls with individual therapist (as required), and ’transitional maintenance’ replacement
medication protocol for stimulant and opiate dependent individuals. Treatment lasting 1 year. N=12.
2. Treatment as usual: continue with individual psychotherapists, or referred to alternative substance
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Linehan 1999 (Continued)
abuse and/or mental health counsellors / programmes. Meetings with case manager as required. Treatment
lasting one year. N=16.
Outcomes Leaving the study early.
Death.
Substance use: time-line follow-back assessment, clean urinalyses.
Unable to use -
Behaviour: parasuicidal acts - PHI (data not reported).
Mental state: anger - STAXI (data not reported).
Service outcomes: medical / psychological treatments received - THI (data not reported).
Quality of life: social adjustment - SHI, GSA, GAS (no N values).
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Linehan 2002
Methods Allocation: minimisation randomisation (matched on severity of DSM-IV drug dependence, presence
/ absence of current cocaine abuse / dependence, presence / absence of DSM-IV antisocial personality
disorder, and global assessment of functioning - DSM-IV Axis V).
Blinding: independent clinical interviewers.
Duration: 1 year treatment + 4 months follow-up.
Setting: outpatient.
Participants Diagnosis: borderline personality disorder (SCID-II and PDE).
N=23.
Sex: women.
Age: mean ~36 (SD 7).
History: diagnosis of current opiate dependence (SCID-I), 52% also met criteria for dependence on
cocaine, 13% on sedatives, 8.7% on cannabis and 26% on alcohol. 65% reported at least one suicide
atttempt / self injury. 44% met criteria for antisocial personality disorder.
Exclusion criteria: bipolar disorder, psychosis, seizure disorder, mental retardation.
Interventions 1. Dialectical behaviour therapy: core elenents of standard manulaised DBT modified for substance abus-
ing population, weekly individual DBT (40-90 mins/week, targetting dysfunctional behaviours, replacing
these with skills learned in psychoeducational skills group, phone consultation and crisis intervention
as needed) + weekly groups skills training (150mins/week, skills training:mindfulness, interpersonal ef-
fectiveness, distress tolerance, emotion regulation). Individual skills coaching (skills strenghtening and
generalization), 12-step (e.g. Alcoholics / Narcotics / Cocaine Anonymous; AA,NA,CA) or other support
groups recommended, opiate replacement medication (levomethadylacetate hydrochloride). N=11.
2. Comprehensive validation therapy + 12-step (CVT+12S): Individual CVT+12S (40-90 mins/week,
DBTacceptance-based strategies, but non-directive)+ ’12-and-12’ Narcotics Anonymous (NA) group (120
mins/week). 12-Step sponsor meeting and 12-Step (AA/NA/CA)meetings recommended. CVT+12S case
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Linehan 2002 (Continued)
management as needed and phone consultation and standard crisis intervention. Opiate replacement
medication (levomethadylacetate hydrochloride). N=12.
Outcomes Leaving the study early.
Prison and service outcomes: time spent in prison.
Unable to use -
Substance use: self-report abstinent days and proportion clean urinalyses (time-line follow-back assess-
ment): reported as probabilities and mean percentages (not usable data).
Behaviour: parasuicidal acts - PHI (no data by treatment group).
Mental state: BSI (no data by treatment group).
Quality of life: social adjustment: SHI, GAS, GSA (no data by treatment group).
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
Turner 2000
Methods Allocation: randomised.
Blinding: blinded, independent rater evaluations (unaware of treatment condition, but aware of study
purpose).
Duration: 1 year.
Setting: outpatient.
Participants Diagnosis: borderline personality disorder (DIB, PDE).
N=24.
Sex: 19 women, 5 men.
Age: average 22 (range 18-27).
History: initially treated in hospital for suicide attempts. 23/24 met criteria for a comorbid Axis I disorder
(17 dysthmia and generalised anxiety disorder), 18 for 2 additional personality disorders (9 dependent,
6 histrionic, 3 schizotypal, 2 paranoid, 2 antisocial, and 1 compulsive personality disorder). 19 taking
psychotropic medication at preassessment.
Exclusion criteria: included a diagnosis of schizophrenia, schizoaffective disorder, organic mental disorder
and mental retardation.
Interventions 1. Dialectical behaviour therapy-oriented treatment: based on Linehan approach but with modifications (
incorporated psychodynamic techniques and no separate DBT skills training group). Skills training during
individual therapy and six group sessions focusing on significant people in their environment. N=12.
2. Client centred therapy: schedules for two times per week over one year (up to three times a week during
crisis management), clinicians provide support to help patients cope with daily stressors and prevent
relapse in non-directivemanner, 4 phases to treatment: crisismanagement, problem assessment, supportive
treatment and termination. N=12.
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Turner 2000 (Continued)
Outcomes Mental state: BDI, BAI, BSSI, BPRS, HRSD.
Service outcomes: admissions.
Unable to use -
Behaviour: parasuicide rating - TBR, parasuicidal acts, impulsiveness rating - TBR (scale not validated or
published in peer reviewed journal).
Mental state: anger rating - TBR.
Helping alliance: HRQ (not a protocol outcome).
Notes * Does not report data for all participants randomised to treatment. Reviewers assume poor outcome for
these people.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
van den Bosch 2002
Methods Allocation: minimisation randomisation (to ensure comparability across groups in age, severity of suicidal
behaviour, substance abuse (drug and alcohol), and social problems).
Blinding: research assessors not informed of treatment condition, but could have been given information
by participants.
Duration: 12 months.
Setting: outpatient.
Participants Diagnosis: borderline personality disorder (PDQ-DSM-IV, SCID-II).
N=64.
Sex: women.
Age: mean ~35 (SD 8).
History: DSM-IV diagnosis of bipolar disorder, (chronic) psychotic disorder and severe cognitive impair-
ments were exclusionary criteria. 31/ 58 who started treatment were substance abusers (>/= 5 on drug/
alcohol section of EuropASI). Clinical referrals primarily from addiction treatment and psychiatric ser-
vices. 75% of patients within each treatment condition used psychotropic medication (benzodiazepines,
antidepressants, mood stabilisers, and neuropleptics).
Interventions 1. Dialectical behaviour therapy: manualised 12 month treatment programme comprising: weekly in-
dividual cognitive behavioural psychotherapy (motivational issues) , weekly group skills training (2-2.5
hours/week, self-regulation and change skills, self and other acceptance)and phone consultation as needed
(coaching in application of new skills). N=31.
2. Treatment as usual: clinical management from original referral source (of those starting treatment:
addiction treatment n=11, psychiatric services n=20). Typically did not attend more than two sessions per
month with a practitioner. N=33.
Outcomes Substance use: EuropASI items.
Leaving the study early.
Behaviour: parasuicidal behaviour (BPDSI) and self-mutilating behaviour (LPC).
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van den Bosch 2002 (Continued)
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear B - Unclear
BAI - Beck Anxiety Inventory
BDI - Beck Depression Inventory
BHS - Beck Hopelessness Scale
BPDSI - Borderline Personality Disorder Severity Index
BPRS - Brief Psychiatric Rating Scale
BSI - Brief Symptom Inventory
BSSI - Beck Scale for Suicide Ideation
DES - Dissociative Experiences Scale
DIB - The Diagnostic Interview for Borderlines
EuropASI - Addiction Severity Index - European Version
GAS - Global Adjustment Scale
GSA - Global Social Adjustment
HAM-D - Hamilton Depression Scale
HARS - Hamilton Anxiety Rating Scale
HRDS - Hamilton Rating Scale for Depression
HRQ - Helping Relationship Questionnaire
Inventory of Interpersonal Problems - circumflex version
LIFE - Social Adjustment Scale - Longitudinal Interview Follow-up
LPC - Lifetime Parasuicide Count.
PDE - International Personality Disorders Examination
PDQ-DSM-IV - Personality Diagnostic Questionnaire, DSM-IV version
PHI - Parasuicide History Interview
RLISC - The Reasons for Living Inventory, Survival and Coping Scale.
SAS-I - Social Adjustment Scale - Interview
SAS-SR - Social Adjustment Scale-Self-Report
SCID-I - Structured Clinical Interview for Axis I DSM-III-R
SCID-II - Structured Clinical Interview for DSM-III-R / DSM-IV Axis-II Personality Disorder
SCL90-R - Symptom Check List 90 - Revised
SHI - Social History Interview
SSHI - Suicide and Self Harm Inventory
SSI - Scale for Suicide Ideators
STAI - Spielberger State Trait Anxiety Inventory
STAS-T - State-Trait Anger Scale
STAXI - Speilberger Anger Expression Scale / State Trait Anger Expression Inventory
TBR - Target Behaviour Ratings
THI - Treatment History Interview
TI - Therapist Interview
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Characteristics of excluded studies [ordered by study ID]
Antikainen 1995 Allocation: not randomised, case series.
Bloxham 1993 Allocation: not randomised, case study.
Blum 2002 Allocation: not randomised, case series.
Bohus 2000 Allocation: not randomised, case series.
Clarkin 1994 Allocation: not randomised, case series.
Corwin 1996 Allocation: not randomised, review and case study.
Cuevas 2000 Allocation: not randomised, case series.
de Zulueta 2000 Allocation: not randomised, review and case studies.
Dimeff 2000 Allocation: not randomised, case series.
Dolan 1996 Allocation: not randomised, prospective survey of service usage.
Dungee-Anderson 1992 Allocation: not randomised, case study.
Eccleston 2002 Allocation: not randomised, case series.
Eckert 2000 Allocation: not randomised, prospective cohort study.
Feeny 2002 Allocation: random.
Diagnosis: chronic PTSD primary diagnosis. 17% of participants met criteria for BPD.
Freeman 2002 Allocation: not randomised, case study.
Gunderson 1989 Allocation: not randomised, case series.
Hafner 1996 Allocation: not randomised, case series.
Heller 1996 Allocation: not randomised, case studies.
Hengeveld 1996 Allocation: not randomised, case series.
Hoffman 1998 Allocation: not randomised, case study.
Hull 1993 Allocation: not randomised, case series.
James 1996 Allocation: not randomised, case control.
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Joyce 1999 Allocation: not randomised, cluster analysis.
Kern 1997 Allocation: not randomised, case studies.
Kerr 1999 Allocation: not randomised, case study.
Kretsch 1987 Allocation: not randomised, case series.
Links 1998 Allocation: not randomised, prospective cohort study.
Low 2001 Allocation: not randomised, case series.
Marcoux 2000 Allocation: not randomised, case studies.
McGlashan 1986 Allocation: not randomised, cohort study.
Meares 1999 Allocation: not randomised, case controlled study.
Mishne 1991 Allocation: not randomised, review and case studies.
Munroe Blum 1988 Allocation: not randomised, case study.
Munroe-Blum 1995 Allocation: block randomisation with allocation concealment.
Participants: people with borderline personality disorder.
Intervention: interpersonal group psychotherapy vs. individual dynamic psychotherapy.
Outcomes: leaving the study early, social functioning, mental state (no usable data - data not presented
by treatment group), group cohesion, alliance (not protocol outcomes).
Najavits 1995 Allocation: not randomised, follow-up study.
Pollock 1998 Allocation: not randomised, case studies.
Quaytman 1997 Allocation: not randomised, case studies.
Ryle 1995 Allocation: not randomised, case studies.
Ryle 2000 Allocation: not randomised, case series.
Sandell 1993 Allocation: not randomised, retrospective, cross-sectional study.
Schimmel 1999 Allocation: not randomised, case study.
Stanley 1998 Allocation: not randomised, matched, controlled study.
Stevenson submitted Allocation: not randomised, prospective cohort study.
Stone 1987a Allocation: not randomised, case series.
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Stone 1987b Allocation: not randomised, case control.
Tucker 1987 Allocation: not randomised, case series.
Waldinger 1984 Allocation: not randomised, case series.
Wheelis 1998 Allocation: not randomised, case study.
Wilberg 1998 Allocation: not randomised, unmatched, controlled.
Wildgoose 2001 Allocation: not randomised, case series.
Yeomans 1993 Allocation: not randomised, process study.
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D A T A A N D A N A L Y S E S
Comparison 1. DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Global: 1. Still meeting SCID-II
criteria for BPD - by 6 months
1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.35, 1.38]
2 Global: 2. Average number of
SCID-II BPD criteria met - by
6 months (skewed data)
Other data No numeric data
3 Service outcomes: 1. Admission
to psychiatric hospital in
previous 3 months - by 6
months
1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.77 [0.28, 2.14]
4 Behaviour: 1a. Self harm -
parasuicide / self-harm (PHI)
2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 within 6 months 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.66 [0.25, 1.75]
4.2 > 6 months to 12 months 1 63 Risk Ratio (M-H, Fixed, 95% CI) 0.81 [0.66, 0.98]
5 Behaviour: 1b. Self harm -
self-mutilating behaviour in
previous 6 months (LPC)
1 64 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.45, 1.06]
5.1 > 6 months to 1 year 1 64 Risk Ratio (M-H, Fixed, 95% CI) 0.69 [0.45, 1.06]
6 Behaviour: 1c. Self harm -
average number of parasuicidal
acts (PHI, skewed data)
Other data No numeric data
6.1 within 6 months Other data No numeric data
6.2 > 6 to 12 months Other data No numeric data
6.3 > 12 to 18 months follow-
up
Other data No numeric data
6.4 > 18 to 24 months follow-
up
Other data No numeric data
7 Behaviour: 1d. Self harm
- average risk scores for
parasuicide episodes - by >6-12
months (PHI, skewed data)
Other data No numeric data
8 Behaviour: 1e. Self harm -
average number of medically
treated parasuicide episodes
(PHI, skewed data)
Other data No numeric data
8.1 by >6 months to 12
months
Other data No numeric data
8.2 by >12 months to 18
months follow-up
Other data No numeric data
8.3 by >18 months to 24
months follow-up
Other data No numeric data
9 Mental state: 1. No clinically
significant change - by 6
months
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
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9.1 anger - in (STAXI) 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.64 [0.29, 1.43]
9.2 anger - out (STAXI) 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.64 [0.29, 1.43]
9.3 depression (BDI) 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.62 [0.36, 1.07]
9.4 dissociation (DES) 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.52 [0.25, 1.11]
9.5 hopelessness (BHS) 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.53 [0.29, 0.99]
9.6 suicidal ideation (BSSI) 1 28 Risk Ratio (M-H, Fixed, 95% CI) 0.62 [0.36, 1.07]
10 Mental state: 2a. Anger -
average scores - by 6 months
(STAXI, high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
10.1 anger - in 1 20 Mean Difference (IV, Fixed, 95% CI) -1.90 [-6.47, 2.67]
10.2 anger - out 1 20 Mean Difference (IV, Fixed, 95% CI) -3.40 [-7.89, 1.09]
11 Mental state: 3a. Anxiety -
average score - by 6 months
(HARS, high = poor)
1 20 Mean Difference (IV, Fixed, 95% CI) -13.10 [-22.08, -
4.12]
12 Mental state: 4a. Depression -
average score - by 6 months
(HAM-D, high = poor)
1 20 Mean Difference (IV, Fixed, 95% CI) -7.20 [-13.19, -1.21]
13 Mental state: 4b. Depression
- average score - by 6 months
(BDI, high = poor, skewed
data)
Other data No numeric data
14 Mental state: 5. Dissociation
- average score - by 6 months
(DES, high = poor, skewed
data)
Other data No numeric data
15 Mental state: 6. Hopelessness
- average score - by 6 months
(BHS, high = poor, skewed
data)
Other data No numeric data
16 Mental state: 7. Suicidal
ideation - average score - by 6
months (BSSI, high = poor)
1 20 Mean Difference (IV, Fixed, 95% CI) -15.3 [-25.46, -5.14]
17 Leaving the study early 3 155 Risk Ratio (M-H, Fixed, 95% CI) 0.74 [0.52, 1.04]
18 Substance use - by 12 to 18
months follow up (EuropASI,
high = poor, skewed data)
Other data No numeric data
18.1 alcohol - average days >4
drinks past months (0-30)
Other data No numeric data
18.2 alcohol - average days
alcohol problems past months
(0-30)
Other data No numeric data
18.3 alcohol - average severity
of alcohol problems (0-9)
Other data No numeric data
18.4 cannabis - average days
cannabis use past months (0-
30)
Other data No numeric data
18.5 drug problems - average
days drug problems past
months (0-30)
Other data No numeric data
18.6 drug problems - average
severity drug problems (0-9)
Other data No numeric data
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18.7 medication - avereage
days medication use past
months (0-30)
Other data No numeric data
Comparison 2. DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs TREATMENT AS USUAL
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death: sudden / unexpected 1 28 Risk Ratio (M-H, Fixed, 95% CI) 3.92 [0.17, 88.67]
2 Leaving the study early 1 28 Risk Ratio (M-H, Fixed, 95% CI) 1.33 [0.50, 3.58]
3 Substance use: Abstinent from
drugs / alcohol - proportion
days (interviewer assessed)
Other data No numeric data
3.1 within 6 months Other data No numeric data
3.2 by >6 to 12 months Other data No numeric data
3.3 by >12 to 18 months
follow-up
Other data No numeric data
4 Substance use: Urinalyses clean -
proportion
Other data No numeric data
4.1 within 6 months Other data No numeric data
4.2 by >6 to 12 months Other data No numeric data
4.3 by >12 to 18 months
follow-up
Other data No numeric data
Comparison 3. DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs COMPREHENSIVE VALI-
DATION THERAPY PLUS 12-STEP
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Service outcomes: 1a. Prison - at
least one night incarcerated -
by >12 to 18 months follow up
1 23 Risk Ratio (M-H, Fixed, 95% CI) 1.09 [0.64, 1.87]
2 Service outcomes: 1b. Prison
- average number of nights
incarcerated - by >12 to 18
months follow up
Other data No numeric data
3 Leaving the study early 1 23 Risk Ratio (M-H, Fixed, 95% CI) 7.58 [0.44, 132.08]
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Comparison 4. DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT CENTRED
THERAPY
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Service outcomes: Admitted to
psychiatric hospital - by 6 to 12
months
1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.08, 1.33]
2 Behaviour: Self harm -
parasuicide and behavioural
indicators - no clinically
significant change (self-report)
1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.13 [0.02, 0.85]
2.1 >6 months to 12 months 1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.13 [0.02, 0.85]
3 Mental state: 1. No clinically
significant change - by 6 to 12
months
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 anxiety (BAI >/=10) 1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.6 [0.32, 1.12]
3.2 depression (BDI >/=10) 1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.52 [0.30, 0.91]
3.3 depression (HDRS >/=10) 1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.43 [0.14, 1.28]
3.4 general psychiatric severity
(BPRS >/=15)
1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.6 [0.37, 0.97]
3.5 suicidal ideation (BSSI >3) 1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.13 [0.02, 0.85]
4 Mental state: 2a. Anxiety /
depression - average score - by
6 months
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
4.1 anxiety (BAI, high = poor) 1 24 Mean Difference (IV, Fixed, 95% CI) -4.50 [-8.80, -0.20]
4.2 depression (BDI, high =
poor)
1 24 Mean Difference (IV, Fixed, 95% CI) -6.67 [-11.95, -1.39]
5 Mental state: 2b. Anxiety /
depression (HDRS, high =
poor, skewed data)
Other data No numeric data
5.1 within 6 months Other data No numeric data
5.2 by >6 to 12 months Other data No numeric data
6 Mental state: 2c. Anxiety /
depression - average score - by
>6 to 12 months (high = poor,
skewed data)
Other data No numeric data
6.1 anxiety (BAI) Other data No numeric data
6.2 depression (BDI) Other data No numeric data
7 Mental state: 3. General
psychiatric severity (BPRS,
high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
7.1 within 6 months 1 24 Mean Difference (IV, Fixed, 95% CI) -7.41 [-13.72, -1.10]
7.2 by >6 to 12 months 1 24 Mean Difference (IV, Fixed, 95% CI) -7.16 [-12.15, -2.17]
8 Mental state: 4. Suicidal ideation
(BSSI, high =poor)
Other data No numeric data
8.1 within 6 months Other data No numeric data
8.2 by >6 to 12 months Other data No numeric data
9 Leaving the study early 1 24 Risk Ratio (M-H, Fixed, 95% CI) 0.67 [0.25, 1.78]
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Comparison 5. PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHI-
ATRIC CARE
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Service outcome: 1a. Admitted
for inpatient treatment - past 6
months
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 >18 to 24 months follow-
up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.05 [0.00, 0.77]
1.2 >24 to 30 months follow-
up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.1 [0.01, 0.72]
1.3 >30 to 36 months follow-
up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.06 [0.01, 0.40]
2 Service outcome: 1b. Average
number of inpatient days
(skewed data)
Other data No numeric data
2.1 >18 to 24 months follow-
up
Other data No numeric data
2.2 >24 to 30 months follow-
up
Other data No numeric data
2.3 >30 to 36 months follow-
up
Other data No numeric data
3 Service outcome: 2a. Partial
hospitalisation
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
3.1 >18 to 24 months follow-
up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.04 [0.00, 0.59]
3.2 >24 to 30 months follow-
up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.05 [0.00, 0.77]
4 Service outcome: 2b. Average
number of days partially
hospitalised (skewed data)
Other data No numeric data
4.1 >18 to 24 months follow-
up
Other data No numeric data
4.2 >24 to 30 months follow-
up
Other data No numeric data
4.3 >30 to 36 months follow-
up
Other data No numeric data
5 Service outcome: 3. Average
number of visits to psychiatric
outpatients (skewed data)
Other data No numeric data
5.1 >18 to 24 months follow-
up
Other data No numeric data
5.2 >24 to 30 months follow-
up
Other data No numeric data
5.3 >30 to 36 months follow-
up
Other data No numeric data
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6 Service outcome: 4. Average
number of days attending
community centre (skewed
data)
Other data No numeric data
6.1 >18 to 24 months follow-
up
Other data No numeric data
6.2 >24 to 30 months follow-
up
Other data No numeric data
6.3 >30 to 36 months follow-
up
Other data No numeric data
7 Service outcome: 5a. Medication
- taking psychotropic
medication (cumulative)
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.44 [0.25, 0.80]
7.1 >30 to 36 months follow-
up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.44 [0.25, 0.80]
8 Service outcome: 5b. Medication
- receiving polypharmacy
(cumulative)
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.19 [0.06, 0.55]
8.1 >30 to 36 months follow-
up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.19 [0.06, 0.55]
9 Mental state: 1a. Anxiety - state
(STAI, high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
9.1 within 6 months 1 38 Mean Difference (IV, Fixed, 95% CI) 0.40 [-6.49, 7.29]
9.2 > 6 months to 12 months 1 38 Mean Difference (IV, Fixed, 95% CI) -7.00 [-15.01, -2.99]
9.3 > 12 months to 18 months 1 38 Mean Difference (IV, Fixed, 95% CI) -13.0 [-19.65, -6.35]
9.4 >18 to 24 months follow-
up
1 36 Mean Difference (IV, Fixed, 95% CI) -9.70 [-16.42, -2.98]
9.5 >24 to 30 months follow-
up
1 36 Mean Difference (IV, Fixed, 95% CI) -14.40 [-21.74, -
7.06]
9.6 >30 to 36 months follow-
up
1 33 Mean Difference (IV, Fixed, 95% CI) -19.80 [-25.81, -
13.79]
10 Mental state: 1b. Anxiety - trait
(STAI, high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
10.1 within 6 months 1 38 Mean Difference (IV, Fixed, 95% CI) -0.20 [-5.19, 4.79]
10.2 > 6 months to 12 months 1 38 Mean Difference (IV, Fixed, 95% CI) -0.20 [-4.78, 4.38]
10.3 >12 months to 18
months
1 38 Mean Difference (IV, Fixed, 95% CI) -4.20 [-9.53, 1.13]
10.4 >18 to 24 months
follow-up
1 37 Mean Difference (IV, Fixed, 95% CI) -2.10 [-8.25, 4.05]
10.5 >24 to 30 months
follow-up
1 37 Mean Difference (IV, Fixed, 95% CI) -3.40 [-9.87, 3.07]
10.6 >30 to 36 months
follow-up
1 37 Mean Difference (IV, Fixed, 95% CI) -8.30 [-14.01, -2.59]
11 Mental state: 2a. Depressed
(BDI scores >/=14)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
11.1 > 12 months to 18
months
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.87 [0.72, 1.04]
11.2 >18 to 24 months
follow-up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.76 [0.58, 1.00]
11.3 >24 to 30 months
follow-up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.52 [0.34, 0.80]
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11.4 >30 to 36 months
follow-up
1 44 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.27, 0.76]
12 Mental state: 2b. Depression
- average score (BDI, high =
poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
12.1 within 6 months 1 38 Mean Difference (IV, Fixed, 95% CI) -0.20 [-6.25, 5.85]
12.2 > 6 months to 12 months 1 38 Mean Difference (IV, Fixed, 95% CI) -8.00 [-13.66, -2.34]
12.3 >12 months to 18
months
1 38 Mean Difference (IV, Fixed, 95% CI) -14.60 [-19.18, -
10.02]
12.4 >18 to 24 months
follow-up
1 38 Mean Difference (IV, Fixed, 95% CI) -9.7 [-14.47, -4.93]
12.5 >24 to 30 months
follow-up
1 38 Mean Difference (IV, Fixed, 95% CI) -8.2 [-12.85, -3.55]
12.6 >30 to 36 months
follow-up
1 38 Mean Difference (IV, Fixed, 95% CI) -8.50 [-13.83, -3.17]
13 Mental state: 3a. Global
severity - average score (SCL90-
R, high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
13.1 within 6 months 1 38 Mean Difference (IV, Fixed, 95% CI) Not estimable
13.2 > 6 months to 12 months 1 38 Mean Difference (IV, Fixed, 95% CI) -0.20 [-0.61, 0.21]
13.3 >12 months to 18
months
1 38 Mean Difference (IV, Fixed, 95% CI) -0.30 [-0.78, 0.18]
13.4 >18 to 24 months
follow-up
1 36 Mean Difference (IV, Fixed, 95% CI) -0.70 [-1.13, -0.27]
14 Mental state: 3b. Global
severity - average score (SCL90-
R, high = poor, skewed data)
Other data No numeric data
14.1 >24 to 30 months
follow-up
Other data No numeric data
14.2 >30 to 36 months
follow-up
Other data No numeric data
15 Mental state: 4. Positive
symptoms - average score
(SCL90-R, high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
15.1 within 6 months 1 38 Mean Difference (IV, Fixed, 95% CI) 3.20 [-4.44, 10.84]
15.2 > 6 months to 12 months 1 38 Mean Difference (IV, Fixed, 95% CI) 3.10 [-6.64, 12.84]
15.3 > 12 months to 18
months
1 38 Mean Difference (IV, Fixed, 95% CI) -2.40 [-12.70, 7.90]
15.4 >18 to 24 months
follow-up
1 36 Mean Difference (IV, Fixed, 95% CI) -12.70 [-22.18, -
3.22]
15.5 >24 to 30 months
follow-up
1 36 Mean Difference (IV, Fixed, 95% CI) -24.1 [-34.13, -
14.07]
15.6 >30 to 36 months
follow-up
1 36 Mean Difference (IV, Fixed, 95% CI) -33.9 [-43.59, -
24.21]
16 Quality of life: 1. Social
adjustment - average score
(SAS-SR, high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
16.1 > 12 months to 18
months
1 39 Mean Difference (IV, Fixed, 95% CI) -0.70 [-1.08, -0.32]
16.2 >30 to 36 months
follow-up
1 39 Mean Difference (IV, Fixed, 95% CI) -1.30 [-1.68, -0.92]
43Psychological therapies for people with borderline personality disorder (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
17 Quality of life: 2. Interpersonal
problems - average score (IIP-
CV, high = poor)
1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
17.1 > 12 months to 18
months
1 40 Mean Difference (IV, Fixed, 95% CI) -0.70 [-0.89, -0.51]
17.2 >30 to 36 months
follow-up
1 40 Mean Difference (IV, Fixed, 95% CI) -1.0 [-1.28, -0.72]
18 Leaving the study early 1 44 Risk Ratio (M-H, Fixed, 95% CI) 1.0 [0.23, 4.42]
Analysis 1.1. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 1 Global: 1. Still meeting SCID-II criteria for BPD - by 6 months.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 1 Global: 1. Still meeting SCID-II criteria for BPD - by 6 months
Study or subgroup DBT TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Koons 2001 6/13 10/15 100.0 % 0.69 [ 0.35, 1.38 ]
Total (95% CI) 13 15 100.0 % 0.69 [ 0.35, 1.38 ]
Total events: 6 (DBT), 10 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 1.05 (P = 0.29)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 1.2. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 2 Global: 2. Average number of SCID-II BPD criteria met - by 6 months (skewed data).
Global: 2. Average number of SCID-II BPD criteria met - by 6 months (skewed data)
Koons 2001 Dialectical Behaviour
Therapy
10 3.6 1.6
Koons 2001 Treatment as usual 10 4.2 2.3
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Analysis 1.3. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 3 Service outcomes: 1. Admission to psychiatric hospital in previous 3 months - by 6 months.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 3 Service outcomes: 1. Admission to psychiatric hospital in previous 3 months - by 6 months
Study or subgroup DBT TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Koons 2001 4/13 6/15 100.0 % 0.77 [ 0.28, 2.14 ]
Total (95% CI) 13 15 100.0 % 0.77 [ 0.28, 2.14 ]
Total events: 4 (DBT), 6 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 0.50 (P = 0.62)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 1.4. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 4 Behaviour: 1a. Self harm - parasuicide / self-harm (PHI).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 4 Behaviour: 1a. Self harm - parasuicide / self-harm (PHI)
Study or subgroup DBT TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 within 6 months
Koons 2001 4/13 7/15 100.0 % 0.66 [ 0.25, 1.75 ]
Subtotal (95% CI) 13 15 100.0 % 0.66 [ 0.25, 1.75 ]
Total events: 4 (DBT), 7 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 0.83 (P = 0.40)
2 > 6 months to 12 months
Linehan 1991 25/32 30/31 100.0 % 0.81 [ 0.66, 0.98 ]
Subtotal (95% CI) 32 31 100.0 % 0.81 [ 0.66, 0.98 ]
Total events: 25 (DBT), 30 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 2.16 (P = 0.031)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 1.5. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 5 Behaviour: 1b. Self harm - self-mutilating behaviour in previous 6 months (LPC).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 5 Behaviour: 1b. Self harm - self-mutilating behaviour in previous 6 months (LPC)
Study or subgroup DBT TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 6 months to 1 year
van den Bosch 2002 15/31 23/33 100.0 % 0.69 [ 0.45, 1.06 ]
Total (95% CI) 31 33 100.0 % 0.69 [ 0.45, 1.06 ]
Total events: 15 (DBT), 23 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 1.67 (P = 0.094)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 1.6. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 6 Behaviour: 1c. Self harm - average number of parasuicidal acts (PHI, skewed data).
Behaviour: 1c. Self harm - average number of parasuicidal acts (PHI, skewed data)
within 6 months
Koons 2001 Dialectical
Behaviour Therapy
10 0.4 1.3
Koons 2001 Treatment as usual 10 1.0 2.2
Linehan 1991 Dialectical
Behaviour Therapy
22 3.50 7.88 z=2.36, p<.01
Linehan 1991 Treatment as usual 22 15.91 25.02
> 6 to 12 months
Linehan 1991 Dialectical
Behaviour Therapy
20 0.55 0.94 z=1.98, p<.05
Linehan 1991 Treatment as usual 21 9.33 26.95
> 12 to 18 months follow-up
Linehan 1991 Dialectical
Behaviour Therapy
19 0.10 0.32 z=3.78, p<.001, one-tailed test.
Linehan 1991 Treatment as usual 20 2.10 2.69
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Behaviour: 1c. Self harm - average number of parasuicidal acts (PHI, skewed data) (Continued)
> 18 to 24 months follow-up
Linehan 1991 Dialectical
Behaviour Therapy
18 0.72 1.56 z=0.98
Linehan 1991 Treatment as usual 18 1.06 1.55
Analysis 1.7. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 7 Behaviour: 1d. Self harm - average risk scores for parasuicide episodes - by >6-12 months (PHI,
skewed data).
Behaviour: 1d. Self harm - average risk scores for parasuicide episodes - by >6-12 months (PHI, skewed data)
Linehan 1991 Dialectical
Behaviour Therapy
14 9.21 8.22 t=1.70, df=28.01, p<.05, by separate estimates of variance.
Linehan 1991 Treatment as usual 21 17.86 20.94
Analysis 1.8. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 8 Behaviour: 1e. Self harm - average number of medically treated parasuicide episodes (PHI, skewed
data).
Behaviour: 1e. Self harm - average number of medically treated parasuicide episodes (PHI, skewed data)
by >6 months to 12 months
Linehan 1991 Dialectical
Behaviour Therapy
14 0.64 1.15 t=1.70, df=29.24, p<.05, by separate estimates of variance.
Linehan 1991 Treatment as usual 21 1.76 2.66
by >12 months to 18 months follow-up
Linehan 1991 Dialectical
Behaviour Therapy
19 0.05 0.23 z=2.56, p<.01, one-tailed test.
Linehan 1991 Treatment as usual 20 0.75 1.45
by >18 months to 24 months follow-up
Linehan 1991 Dialectical
Behaviour Therapy
18 0.11 0.11 z=0.04
Linehan 1991 Treatment as usual 18 0.56 0.24
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Analysis 1.9. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 9 Mental state: 1. No clinically significant change - by 6 months.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 9 Mental state: 1. No clinically significant change - by 6 months
Study or subgroup DBT TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 anger - in (STAXI)
Koons 2001 5/13 9/15 100.0 % 0.64 [ 0.29, 1.43 ]
Subtotal (95% CI) 13 15 100.0 % 0.64 [ 0.29, 1.43 ]
Total events: 5 (DBT), 9 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 1.09 (P = 0.28)
2 anger - out (STAXI)
Koons 2001 5/13 9/15 100.0 % 0.64 [ 0.29, 1.43 ]
Subtotal (95% CI) 13 15 100.0 % 0.64 [ 0.29, 1.43 ]
Total events: 5 (DBT), 9 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 1.09 (P = 0.28)
3 depression (BDI)
Koons 2001 7/13 13/15 100.0 % 0.62 [ 0.36, 1.07 ]
Subtotal (95% CI) 13 15 100.0 % 0.62 [ 0.36, 1.07 ]
Total events: 7 (DBT), 13 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 1.72 (P = 0.085)
4 dissociation (DES)
Koons 2001 5/13 11/15 100.0 % 0.52 [ 0.25, 1.11 ]
Subtotal (95% CI) 13 15 100.0 % 0.52 [ 0.25, 1.11 ]
Total events: 5 (DBT), 11 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 1.68 (P = 0.093)
5 hopelessness (BHS)
Koons 2001 6/13 13/15 100.0 % 0.53 [ 0.29, 0.99 ]
Subtotal (95% CI) 13 15 100.0 % 0.53 [ 0.29, 0.99 ]
Total events: 6 (DBT), 13 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 1.99 (P = 0.046)
6 suicidal ideation (BSSI)
Koons 2001 7/13 13/15 100.0 % 0.62 [ 0.36, 1.07 ]
Subtotal (95% CI) 13 15 100.0 % 0.62 [ 0.36, 1.07 ]
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
(Continued . . . )
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(. . . Continued)
Study or subgroup DBT TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Total events: 7 (DBT), 13 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 1.72 (P = 0.085)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 1.10. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 10 Mental state: 2a. Anger - average scores - by 6 months (STAXI, high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 10 Mental state: 2a. Anger - average scores - by 6 months (STAXI, high = poor)
Study or subgroup DBT TAU Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 anger - in
Koons 2001 10 17.3 (4) 10 19.2 (6.2) 100.0 % -1.90 [ -6.47, 2.67 ]
Subtotal (95% CI) 10 10 100.0 % -1.90 [ -6.47, 2.67 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
2 anger - out
Koons 2001 10 14.5 (3.9) 10 17.9 (6.1) 100.0 % -3.40 [ -7.89, 1.09 ]
Subtotal (95% CI) 10 10 100.0 % -3.40 [ -7.89, 1.09 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Chi2 = 0.21, df = 1 (P = 0.65), I2 =0.0%
-10 -5 0 5 10
Favours treatment Favours control
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Analysis 1.11. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 11 Mental state: 3a. Anxiety - average score - by 6 months (HARS, high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 11 Mental state: 3a. Anxiety - average score - by 6 months (HARS, high = poor)
Study or subgroup DBT TAU Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Koons 2001 10 19.1 (7.5) 10 32.2 (12.4) 100.0 % -13.10 [ -22.08, -4.12 ]
Total (95% CI) 10 10 100.0 % -13.10 [ -22.08, -4.12 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.86 (P = 0.0043)
-10 -5 0 5 10
Favours treatment Favours control
Analysis 1.12. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 12 Mental state: 4a. Depression - average score - by 6 months (HAM-D, high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 12 Mental state: 4a. Depression - average score - by 6 months (HAM-D, high = poor)
Study or subgroup DBT TAU Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Koons 2001 10 17.1 (5.7) 10 24.3 (7.8) 100.0 % -7.20 [ -13.19, -1.21 ]
Total (95% CI) 10 10 100.0 % -7.20 [ -13.19, -1.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.36 (P = 0.018)
-10 -5 0 5 10
Favours treatment Favours control
Analysis 1.13. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 13 Mental state: 4b. Depression - average score - by 6 months (BDI, high = poor, skewed data).
Mental state: 4b. Depression - average score - by 6 months (BDI, high = poor, skewed data)
Koons 2001 Dialectical Behaviour
Therapy
10 13.4 7.5
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Mental state: 4b. Depression - average score - by 6 months (BDI, high = poor, skewed data) (Continued)
Koons 2001 Treatment as usual 10 29.3 17.7
Analysis 1.14. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 14 Mental state: 5. Dissociation - average score - by 6 months (DES, high = poor, skewed data).
Mental state: 5. Dissociation - average score - by 6 months (DES, high = poor, skewed data)
Koons 2001 Dilaectical Behaviour
Therapy
10 13.2 12.0
Koons 2001 Treatment as usual 10 30.6 23.3
Analysis 1.15. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 15 Mental state: 6. Hopelessness - average score - by 6 months (BHS, high = poor, skewed data).
Mental state: 6. Hopelessness - average score - by 6 months (BHS, high = poor, skewed data)
Koons 2001 Dialectical Behaviour
Therapy
10 5.1 5.3
Koons 2001 Treatment as usual 10 14.2 7.3
Analysis 1.16. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 16 Mental state: 7. Suicidal ideation - average score - by 6 months (BSSI, high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 16 Mental state: 7. Suicidal ideation - average score - by 6 months (BSSI, high = poor)
Study or subgroup DBT TAU Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Koons 2001 10 26.2 (8) 10 41.5 (14.3) 100.0 % -15.30 [ -25.46, -5.14 ]
Total (95% CI) 10 10 100.0 % -15.30 [ -25.46, -5.14 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.95 (P = 0.0031)
-10 -5 0 5 10
Favours treatment Favours control
51Psychological therapies for people with borderline personality disorder (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.17. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 17 Leaving the study early.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL
Outcome: 17 Leaving the study early
Study or subgroup DBT TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Koons 2001 3/13 5/15 11.6 % 0.69 [ 0.20, 2.35 ]
Linehan 1991 12/32 10/31 25.4 % 1.16 [ 0.59, 2.29 ]
van den Bosch 2002 14/31 26/33 63.0 % 0.57 [ 0.37, 0.88 ]
Total (95% CI) 76 79 100.0 % 0.74 [ 0.52, 1.04 ]
Total events: 29 (DBT), 41 (TAU)
Heterogeneity: Chi2 = 3.08, df = 2 (P = 0.21); I2 =35%
Test for overall effect: Z = 1.71 (P = 0.086)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 1.18. Comparison 1 DIALECTICAL BEHAVIOUR THERAPY vs TREATMENT AS USUAL,
Outcome 18 Substance use - by 12 to 18 months follow up (EuropASI, high = poor, skewed data).
Substance use - by 12 to 18 months follow up (EuropASI, high = poor, skewed data)
alcohol - average days >4 drinks past months (0-30)
van den Bosch 2002 Dialectical
Behaviour Therapy
20 6.1 9.8 F=0.9, p=.34
van den Bosch 2002 Treatment as usual 24 3.8 7.8
alcohol - average days alcohol problems past months (0-30)
van den Bosch 2002 Dialectical
Behaviour Therapy
20 7.0 11.3 F=0.0, p=.89
van den Bosch 2002 Treatment as usual 24 6.7 11.3
alcohol - average severity of alcohol problems (0-9)
van den Bosch 2002 Dialectical
Behaviour Therapy
20 2.8 2.6 F=1.1, p=.31
van den Bosch 2002 Treatment as usual 24 2.4 2.1
cannabis - average days cannabis use past months (0-30)
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Substance use - by 12 to 18 months follow up (EuropASI, high = poor, skewed data) (Continued)
van den Bosch 2002 Dialectical
Behaviour Therapy
20 9.2 13.3 F=0.1, p=.73
van den Bosch 2002 Treatment as usual 24 5.9 11.5
drug problems - average days drug problems past months (0-30)
van den Bosch 2002 Dialectical
Behaviour Therapy
20 9.5 13.2 F=2.0, p=.17
van den Bosch 2002 Treatment as usual 24 4.5 10.0
drug problems - average severity drug problems (0-9)
van den Bosch 2002 Dialectical
Behaviour Therapy
20 2.8 2.2 F=0.5, p=.47
van den Bosch 2002 Treatment as usual 24 2.3 1.8
medication - avereage days medication use past months (0-30)
van den Bosch 2002 Dialectical
Behaviour Therapy
20 7.9 12.2 F=0.4, p=.54
van den Bosch 2002 Treatment as usual 24 11.5 13.9
Analysis 2.1. Comparison 2 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs TREATMENT
AS USUAL, Outcome 1 Death: sudden / unexpected.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 2 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs TREATMENT AS USUAL
Outcome: 1 Death: sudden / unexpected
Study or subgroup DBT - substance use TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Linehan 1999 1/12 0/16 100.0 % 3.92 [ 0.17, 88.67 ]
Total (95% CI) 12 16 100.0 % 3.92 [ 0.17, 88.67 ]
Total events: 1 (DBT - substance use), 0 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 0.86 (P = 0.39)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 2.2. Comparison 2 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs TREATMENT
AS USUAL, Outcome 2 Leaving the study early.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 2 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs TREATMENT AS USUAL
Outcome: 2 Leaving the study early
Study or subgroup DBT - substance use TAU Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Linehan 1999 5/12 5/16 100.0 % 1.33 [ 0.50, 3.58 ]
Total (95% CI) 12 16 100.0 % 1.33 [ 0.50, 3.58 ]
Total events: 5 (DBT - substance use), 5 (TAU)
Heterogeneity: not applicable
Test for overall effect: Z = 0.57 (P = 0.57)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 2.3. Comparison 2 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs TREATMENT
AS USUAL, Outcome 3 Substance use: Abstinent from drugs / alcohol - proportion days (interviewer assessed).
Substance use: Abstinent from drugs / alcohol - proportion days (interviewer assessed)
within 6 months
Linehan 1999 Dialectical
Behaviour Therapy
12 0.63 0.34 F=3.16, p<.05
Linehan 1999 Treatment as usual 16 0.32 0.37
by >6 to 12 months
Linehan 1999 Dialectical
Behaviour Therapy
12 0.67 0.38 F=1.67
Linehan 1999 Treatment as usual 16 0.39 0.44
by >12 to 18 months follow-up
Linehan 1999 Dialectical
Behaviour Therapy
12 0.94 0.17 F=4.04, p<.05
Linehan 1999 Treatment as usual 16 0.58 0.36
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Analysis 2.4. Comparison 2 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs TREATMENT
AS USUAL, Outcome 4 Substance use: Urinalyses clean - proportion.
Substance use: Urinalyses clean - proportion
within 6 months
Linehan 1999 Dialectical
Behaviour Therapy
12 0.38 0.43 F=2.13, p<.10
Linehan 1999 Treatment as usual 16 0.22 0.31
by >6 to 12 months
Linehan 1999 Dialectical
Behaviour Therapy
12 0.33 0.39 F=0.57
Linehan 1999 Treatment as usual 16 0.25 0.41
by >12 to 18 months follow-up
Linehan 1999 Dialectical
Behaviour Therapy
12 0.29 0.40 F=2.41, p<.10
Linehan 1999 Treatment as usual 16 0.13 0.29
Analysis 3.1. Comparison 3 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs
COMPREHENSIVE VALIDATION THERAPY PLUS 12-STEP, Outcome 1 Service outcomes: 1a. Prison - at
least one night incarcerated - by >12 to 18 months follow up.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 3 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs COMPREHENSIVE VALIDATION THERAPY PLUS 12-STEP
Outcome: 1 Service outcomes: 1a. Prison - at least one night incarcerated - by >12 to 18 months follow up
Study or subgroup DBT - substance use CVT+12S Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Linehan 2002 8/11 8/12 100.0 % 1.09 [ 0.64, 1.87 ]
Total (95% CI) 11 12 100.0 % 1.09 [ 0.64, 1.87 ]
Total events: 8 (DBT - substance use), 8 (CVT+12S)
Heterogeneity: not applicable
Test for overall effect: Z = 0.32 (P = 0.75)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 3.2. Comparison 3 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs
COMPREHENSIVE VALIDATION THERAPY PLUS 12-STEP, Outcome 2 Service outcomes: 1b. Prison -
average number of nights incarcerated - by >12 to 18 months follow up.
Service outcomes: 1b. Prison - average number of nights incarcerated - by >12 to 18 months follow up
Linehan 2002 Dialectical
Behaviour Therapy
8 7.7 14.5 * Report no statistically significant difference between conditions. Statis-
tics not reported.
Linehan 2002 Comprehensive vali-
dation therapy + 12
step
8 18.8 34.4
Analysis 3.3. Comparison 3 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs
COMPREHENSIVE VALIDATION THERAPY PLUS 12-STEP, Outcome 3 Leaving the study early.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 3 DIALECTICAL BEHAVIOUR THERAPY - SUBSTANCE USE vs COMPREHENSIVE VALIDATION THERAPY PLUS 12-STEP
Outcome: 3 Leaving the study early
Study or subgroup DBT - substance use CVT+12S Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Linehan 2002 3/11 0/12 100.0 % 7.58 [ 0.44, 132.08 ]
Total (95% CI) 11 12 100.0 % 7.58 [ 0.44, 132.08 ]
Total events: 3 (DBT - substance use), 0 (CVT+12S)
Heterogeneity: not applicable
Test for overall effect: Z = 1.39 (P = 0.16)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 4.1. Comparison 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT
CENTRED THERAPY, Outcome 1 Service outcomes: Admitted to psychiatric hospital - by 6 to 12 months.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT CENTRED THERAPY
Outcome: 1 Service outcomes: Admitted to psychiatric hospital - by 6 to 12 months
Study or subgroup DBT-ORIENTED CCT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Turner 2000 2/12 6/12 100.0 % 0.33 [ 0.08, 1.33 ]
Total (95% CI) 12 12 100.0 % 0.33 [ 0.08, 1.33 ]
Total events: 2 (DBT-ORIENTED), 6 (CCT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.55 (P = 0.12)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
Analysis 4.2. Comparison 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT
CENTRED THERAPY, Outcome 2 Behaviour: Self harm - parasuicide and behavioural indicators - no clinically
significant change (self-report).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT CENTRED THERAPY
Outcome: 2 Behaviour: Self harm - parasuicide and behavioural indicators - no clinically significant change (self-report)
Study or subgroup DBT-ORIENTED CCT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 >6 months to 12 months
Turner 2000 1/12 8/12 100.0 % 0.13 [ 0.02, 0.85 ]
Total (95% CI) 12 12 100.0 % 0.13 [ 0.02, 0.85 ]
Total events: 1 (DBT-ORIENTED), 8 (CCT)
Heterogeneity: not applicable
Test for overall effect: Z = 2.12 (P = 0.034)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 4.3. Comparison 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT
CENTRED THERAPY, Outcome 3 Mental state: 1. No clinically significant change - by 6 to 12 months.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT CENTRED THERAPY
Outcome: 3 Mental state: 1. No clinically significant change - by 6 to 12 months
Study or subgroup DBT-ORIENTED CCT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 anxiety (BAI >/=10)
Turner 2000 6/12 10/12 100.0 % 0.60 [ 0.32, 1.12 ]
Subtotal (95% CI) 12 12 100.0 % 0.60 [ 0.32, 1.12 ]
Total events: 6 (DBT-ORIENTED), 10 (CCT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.62 (P = 0.11)
2 depression (BDI >/=10)
Turner 2000 6/12 12/12 100.0 % 0.52 [ 0.30, 0.91 ]
Subtotal (95% CI) 12 12 100.0 % 0.52 [ 0.30, 0.91 ]
Total events: 6 (DBT-ORIENTED), 12 (CCT)
Heterogeneity: not applicable
Test for overall effect: Z = 2.31 (P = 0.021)
3 depression (HDRS >/=10)
Turner 2000 3/12 7/12 100.0 % 0.43 [ 0.14, 1.28 ]
Subtotal (95% CI) 12 12 100.0 % 0.43 [ 0.14, 1.28 ]
Total events: 3 (DBT-ORIENTED), 7 (CCT)
Heterogeneity: not applicable
Test for overall effect: Z = 1.52 (P = 0.13)
4 general psychiatric severity (BPRS >/=15)
Turner 2000 7/12 12/12 100.0 % 0.60 [ 0.37, 0.97 ]
Subtotal (95% CI) 12 12 100.0 % 0.60 [ 0.37, 0.97 ]
Total events: 7 (DBT-ORIENTED), 12 (CCT)
Heterogeneity: not applicable
Test for overall effect: Z = 2.09 (P = 0.036)
5 suicidal ideation (BSSI >3)
Turner 2000 1/12 8/12 100.0 % 0.13 [ 0.02, 0.85 ]
Subtotal (95% CI) 12 12 100.0 % 0.13 [ 0.02, 0.85 ]
Total events: 1 (DBT-ORIENTED), 8 (CCT)
Heterogeneity: not applicable
Test for overall effect: Z = 2.12 (P = 0.034)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 4.4. Comparison 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT
CENTRED THERAPY, Outcome 4 Mental state: 2a. Anxiety / depression - average score - by 6 months.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT CENTRED THERAPY
Outcome: 4 Mental state: 2a. Anxiety / depression - average score - by 6 months
Study or subgroup DBT-ORIENTED CCT Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 anxiety (BAI, high = poor)
Turner 2000 12 12.58 (4.89) 12 17.08 (5.82) 100.0 % -4.50 [ -8.80, -0.20 ]
Subtotal (95% CI) 12 12 100.0 % -4.50 [ -8.80, -0.20 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.05 (P = 0.040)
2 depression (BDI, high = poor)
Turner 2000 12 18.08 (7.91) 12 24.75 (4.94) 100.0 % -6.67 [ -11.95, -1.39 ]
Subtotal (95% CI) 12 12 100.0 % -6.67 [ -11.95, -1.39 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.48 (P = 0.013)
Test for subgroup differences: Chi2 = 0.39, df = 1 (P = 0.53), I2 =0.0%
-10 -5 0 5 10
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Analysis 4.5. Comparison 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT
CENTRED THERAPY, Outcome 5 Mental state: 2b. Anxiety / depression (HDRS, high = poor, skewed data).
Mental state: 2b. Anxiety / depression (HDRS, high = poor, skewed data)
within 6 months
Turner 2000 Dialectical
Behaviour Therapy -
Oriented Treatment
12 8.58 6.58
Turner 2000 Client Centred
Therapy
12 13.67 2.93
by >6 to 12 months
Turner 2000 Dialectical
Behaviour Therapy -
Oriented Treatment
12 7.50 5.96
Turner 2000 Client Centred
Therapy
12 12.58 3.90
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Analysis 4.6. Comparison 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT
CENTRED THERAPY, Outcome 6 Mental state: 2c. Anxiety / depression - average score - by >6 to 12 months
(high = poor, skewed data).
Mental state: 2c. Anxiety / depression - average score - by >6 to 12 months (high = poor, skewed data)
anxiety (BAI)
Turner 2000 Dialectical
Behaviour Therapy -
Oriented Treatment
12 10.17 6.53
Turner 2000 ClientCentredTher-
apy
12 14.83 6.34
depression (BDI)
Turner 2000 Dialectical
Behaviour Therapy -
Oriented Treatment
12 14.92 8.26
Turner 2000 ClientCentredTher-
apy
12 24.08 5.55
Analysis 4.7. Comparison 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT
CENTRED THERAPY, Outcome 7 Mental state: 3. General psychiatric severity (BPRS, high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT CENTRED THERAPY
Outcome: 7 Mental state: 3. General psychiatric severity (BPRS, high = poor)
Study or subgroup DBT-ORIENTED CCT Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 within 6 months
Turner 2000 12 18.42 (7.33) 12 25.83 (8.4) 100.0 % -7.41 [ -13.72, -1.10 ]
Subtotal (95% CI) 12 12 100.0 % -7.41 [ -13.72, -1.10 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.30 (P = 0.021)
2 by >6 to 12 months
Turner 2000 12 18.17 (7.9) 12 25.33 (3.94) 100.0 % -7.16 [ -12.15, -2.17 ]
Subtotal (95% CI) 12 12 100.0 % -7.16 [ -12.15, -2.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.81 (P = 0.0050)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.95), I2 =0.0%
-10 -5 0 5 10
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Analysis 4.8. Comparison 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT
CENTRED THERAPY, Outcome 8 Mental state: 4. Suicidal ideation (BSSI, high =poor).
Mental state: 4. Suicidal ideation (BSSI, high =poor)
within 6 months
Turner 2000 Dialectical
Behaviour Therapy-
Oriented Treatment
12 2.83 3.49
Turner 2000 Client Centred
Therapy
12 13.33 9.79
by >6 to 12 months
Turner 2000 Dialectical
Behaviour Therapy-
Oriented Treatment
12 3.83 8.03
Turner 2000 Client Centred
Therapy
12 11.58 9.21
Analysis 4.9. Comparison 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT
CENTRED THERAPY, Outcome 9 Leaving the study early.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 4 DIALECTICAL BEHAVIOUR THERAPY-ORIENTED TREATMENT vs CLIENT CENTRED THERAPY
Outcome: 9 Leaving the study early
Study or subgroup DBT-ORIENTED CCT Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Turner 2000 4/12 6/12 100.0 % 0.67 [ 0.25, 1.78 ]
Total (95% CI) 12 12 100.0 % 0.67 [ 0.25, 1.78 ]
Total events: 4 (DBT-ORIENTED), 6 (CCT)
Heterogeneity: not applicable
Test for overall effect: Z = 0.81 (P = 0.42)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
61Psychological therapies for people with borderline personality disorder (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 5.1. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 1 Service outcome: 1a. Admitted for inpatient treatment - past 6
months.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 1 Service outcome: 1a. Admitted for inpatient treatment - past 6 months
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 >18 to 24 months follow-up
Bateman 1999 0/22 10/22 100.0 % 0.05 [ 0.00, 0.77 ]
Subtotal (95% CI) 22 22 100.0 % 0.05 [ 0.00, 0.77 ]
Total events: 0 (PARTIAL HOSPITAL), 10 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 2.15 (P = 0.032)
2 >24 to 30 months follow-up
Bateman 1999 1/22 10/22 100.0 % 0.10 [ 0.01, 0.72 ]
Subtotal (95% CI) 22 22 100.0 % 0.10 [ 0.01, 0.72 ]
Total events: 1 (PARTIAL HOSPITAL), 10 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 2.29 (P = 0.022)
3 >30 to 36 months follow-up
Bateman 1999 1/22 17/22 100.0 % 0.06 [ 0.01, 0.40 ]
Subtotal (95% CI) 22 22 100.0 % 0.06 [ 0.01, 0.40 ]
Total events: 1 (PARTIAL HOSPITAL), 17 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 2.88 (P = 0.0040)
0.1 0.2 0.5 1 2 5 10
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Analysis 5.2. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 2 Service outcome: 1b. Average number of inpatient days (skewed
data).
Service outcome: 1b. Average number of inpatient days (skewed data)
>18 to 24 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 0.0 0.0 Mann-Whitney U=143, p<0.005.
Bateman 1999 General Psychiatric
Care
19 6.0 10.8
>24 to 30 months follow-up
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Service outcome: 1b. Average number of inpatient days (skewed data) (Continued)
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 0.9 4.3 Mann-Whitney U=138, p<0.007.
Bateman 1999 General Psychiatric
Care
19 12.7 19.4
>30 to 36 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 1.7 5.8 Mann-Whitney U=72, p<0.001.
Bateman 1999 General Psychiatric
Care
19 15.8 12.9
Analysis 5.3. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 3 Service outcome: 2a. Partial hospitalisation.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 3 Service outcome: 2a. Partial hospitalisation
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 >18 to 24 months follow-up
Bateman 1999 0/22 13/22 100.0 % 0.04 [ 0.00, 0.59 ]
Subtotal (95% CI) 22 22 100.0 % 0.04 [ 0.00, 0.59 ]
Total events: 0 (PARTIAL HOSPITAL), 13 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 2.34 (P = 0.019)
2 >24 to 30 months follow-up
Bateman 1999 0/22 10/22 100.0 % 0.05 [ 0.00, 0.77 ]
Subtotal (95% CI) 22 22 100.0 % 0.05 [ 0.00, 0.77 ]
Total events: 0 (PARTIAL HOSPITAL), 10 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 2.15 (P = 0.032)
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Analysis 5.4. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 4 Service outcome: 2b. Average number of days partially
hospitalised (skewed data).
Service outcome: 2b. Average number of days partially hospitalised (skewed data)
>18 to 24 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 0.0 0.0 Mann-Whitney U=99, p<0.001.
Bateman 1999 General Psychiatric
Care
19 12.9 18.7
>24 to 30 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 0.0 0.0 Mann-Whitney U=132, p<0.002.
Bateman 1999 General Psychiatric
Care
19 9.1 14.7
>30 to 36 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 0.0 0.0 Mann-Whitney U=132, p<0.002.
Bateman 1999 General Psychiatric
Care
19 13.9 21.3
Analysis 5.5. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 5 Service outcome: 3. Average number of visits to psychiatric
outpatients (skewed data).
Service outcome: 3. Average number of visits to psychiatric outpatients (skewed data)
>18 to 24 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 0.8 0.6 Mann-Whitney U=59, p<0.001.
Bateman 1999 General Psychiatric
Care
19 4.4 5.7
>24 to 30 months follow-up
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Service outcome: 3. Average number of visits to psychiatric outpatients (skewed data) (Continued)
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 0.7 0.6 Mann-Whitney U=86, p<0.001.
Bateman 1999 General Psychiatric
Care
19 4.4 3.7
>30 to 36 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 0.7 0.6 Mann-Whitney U=73, p<0.001.
Bateman 1999 General Psychiatric
Care
19 4.3 4.6
Analysis 5.6. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 6 Service outcome: 4. Average number of days attending
community centre (skewed data).
Service outcome: 4. Average number of days attending community centre (skewed data)
>18 to 24 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 7.6 13.3 No statistically significant difference (Mann-Whitney U statistic
not reported).
Bateman 1999 General Psychiatric
Care
19 14.0 16.2
>24 to 30 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 4.0 9.8 Mann-Whitney U=91.5, p<0.001.
Bateman 1999 General Psychiatric
Care
19 23.5 21.9
>30 to 36 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
22 0.9 2.9 Mann-Whitney U=87, p<0.001.
Bateman 1999 General Psychiatric
Care
19 17.3 18.3
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Analysis 5.7. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 7 Service outcome: 5a. Medication - taking psychotropic
medication (cumulative).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 7 Service outcome: 5a. Medication - taking psychotropic medication (cumulative)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 >30 to 36 months follow-up
Bateman 1999 8/22 18/22 100.0 % 0.44 [ 0.25, 0.80 ]
Total (95% CI) 22 22 100.0 % 0.44 [ 0.25, 0.80 ]
Total events: 8 (PARTIAL HOSPITAL), 18 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 2.71 (P = 0.0068)
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Analysis 5.8. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 8 Service outcome: 5b. Medication - receiving polypharmacy
(cumulative).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 8 Service outcome: 5b. Medication - receiving polypharmacy (cumulative)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 >30 to 36 months follow-up
Bateman 1999 3/22 16/22 100.0 % 0.19 [ 0.06, 0.55 ]
Total (95% CI) 22 22 100.0 % 0.19 [ 0.06, 0.55 ]
Total events: 3 (PARTIAL HOSPITAL), 16 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 3.03 (P = 0.0024)
0.1 0.2 0.5 1 2 5 10
Favours treatment Favours control
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Analysis 5.9. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 9 Mental state: 1a. Anxiety - state (STAI, high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 9 Mental state: 1a. Anxiety - state (STAI, high = poor)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 within 6 months
Bateman 1999 19 64.3 (12.1) 19 63.9 (9.4) 100.0 % 0.40 [ -6.49, 7.29 ]
Subtotal (95% CI) 19 19 100.0 % 0.40 [ -6.49, 7.29 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.11 (P = 0.91)
2 > 6 months to 12 months
Bateman 1999 19 55.6 (9.8) 19 64.6 (9.1) 100.0 % -9.00 [ -15.01, -2.99 ]
Subtotal (95% CI) 19 19 100.0 % -9.00 [ -15.01, -2.99 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.93 (P = 0.0034)
3 > 12 months to 18 months
Bateman 1999 19 52.5 (11.5) 19 65.5 (9.3) 100.0 % -13.00 [ -19.65, -6.35 ]
Subtotal (95% CI) 19 19 100.0 % -13.00 [ -19.65, -6.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.83 (P = 0.00013)
4 >18 to 24 months follow-up
Bateman 1999 22 48.5 (8.7) 14 58.2 (10.8) 100.0 % -9.70 [ -16.42, -2.98 ]
Subtotal (95% CI) 22 14 100.0 % -9.70 [ -16.42, -2.98 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.83 (P = 0.0047)
5 >24 to 30 months follow-up
Bateman 1999 22 39.1 (8.4) 14 53.5 (12.3) 100.0 % -14.40 [ -21.74, -7.06 ]
Subtotal (95% CI) 22 14 100.0 % -14.40 [ -21.74, -7.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.85 (P = 0.00012)
6 >30 to 36 months follow-up
Bateman 1999 19 32.6 (5.9) 14 52.4 (10.3) 100.0 % -19.80 [ -25.81, -13.79 ]
Subtotal (95% CI) 19 14 100.0 % -19.80 [ -25.81, -13.79 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.45 (P < 0.00001)
Test for subgroup differences: Chi2 = 20.47, df = 5 (P = 0.00), I2 =76%
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Analysis 5.10. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 10 Mental state: 1b. Anxiety - trait (STAI, high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 10 Mental state: 1b. Anxiety - trait (STAI, high = poor)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 within 6 months
Bateman 1999 19 62.3 (9.8) 19 62.5 (5.2) 100.0 % -0.20 [ -5.19, 4.79 ]
Subtotal (95% CI) 19 19 100.0 % -0.20 [ -5.19, 4.79 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.08 (P = 0.94)
2 > 6 months to 12 months
Bateman 1999 19 60.4 (7.4) 19 60.6 (7) 100.0 % -0.20 [ -4.78, 4.38 ]
Subtotal (95% CI) 19 19 100.0 % -0.20 [ -4.78, 4.38 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.09 (P = 0.93)
3 >12 months to 18 months
Bateman 1999 19 56.8 (9.1) 19 61 (7.6) 100.0 % -4.20 [ -9.53, 1.13 ]
Subtotal (95% CI) 19 19 100.0 % -4.20 [ -9.53, 1.13 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.54 (P = 0.12)
4 >18 to 24 months follow-up
Bateman 1999 22 54.4 (8) 15 56.5 (10.2) 100.0 % -2.10 [ -8.25, 4.05 ]
Subtotal (95% CI) 22 15 100.0 % -2.10 [ -8.25, 4.05 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.67 (P = 0.50)
5 >24 to 30 months follow-up
Bateman 1999 22 43.1 (9) 15 46.5 (10.4) 100.0 % -3.40 [ -9.87, 3.07 ]
Subtotal (95% CI) 22 15 100.0 % -3.40 [ -9.87, 3.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.03 (P = 0.30)
6 >30 to 36 months follow-up
Bateman 1999 22 34.4 (6.1) 15 42.7 (10.1) 100.0 % -8.30 [ -14.01, -2.59 ]
Subtotal (95% CI) 22 15 100.0 % -8.30 [ -14.01, -2.59 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.85 (P = 0.0044)
Test for subgroup differences: Chi2 = 6.19, df = 5 (P = 0.29), I2 =19%
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Analysis 5.11. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 11 Mental state: 2a. Depressed (BDI scores >/=14).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 11 Mental state: 2a. Depressed (BDI scores >/=14)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 > 12 months to 18 months
Bateman 1999 19/22 22/22 100.0 % 0.87 [ 0.72, 1.04 ]
Subtotal (95% CI) 22 22 100.0 % 0.87 [ 0.72, 1.04 ]
Total events: 19 (PARTIAL HOSPITAL), 22 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 1.53 (P = 0.13)
2 >18 to 24 months follow-up
Bateman 1999 16/22 21/22 100.0 % 0.76 [ 0.58, 1.00 ]
Subtotal (95% CI) 22 22 100.0 % 0.76 [ 0.58, 1.00 ]
Total events: 16 (PARTIAL HOSPITAL), 21 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 1.96 (P = 0.050)
3 >24 to 30 months follow-up
Bateman 1999 11/22 21/22 100.0 % 0.52 [ 0.34, 0.80 ]
Subtotal (95% CI) 22 22 100.0 % 0.52 [ 0.34, 0.80 ]
Total events: 11 (PARTIAL HOSPITAL), 21 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 2.96 (P = 0.0030)
4 >30 to 36 months follow-up
Bateman 1999 9/22 20/22 100.0 % 0.45 [ 0.27, 0.76 ]
Subtotal (95% CI) 22 22 100.0 % 0.45 [ 0.27, 0.76 ]
Total events: 9 (PARTIAL HOSPITAL), 20 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 3.01 (P = 0.0026)
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Analysis 5.12. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 12 Mental state: 2b. Depression - average score (BDI, high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 12 Mental state: 2b. Depression - average score (BDI, high = poor)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 within 6 months
Bateman 1999 19 36.3 (8.9) 19 36.5 (10.1) 100.0 % -0.20 [ -6.25, 5.85 ]
Subtotal (95% CI) 19 19 100.0 % -0.20 [ -6.25, 5.85 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
2 > 6 months to 12 months
Bateman 1999 19 26.7 (8.7) 19 34.7 (9.1) 100.0 % -8.00 [ -13.66, -2.34 ]
Subtotal (95% CI) 19 19 100.0 % -8.00 [ -13.66, -2.34 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.77 (P = 0.0056)
3 >12 months to 18 months
Bateman 1999 19 20.6 (7) 19 35.2 (7.4) 100.0 % -14.60 [ -19.18, -10.02 ]
Subtotal (95% CI) 19 19 100.0 % -14.60 [ -19.18, -10.02 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.25 (P < 0.00001)
4 >18 to 24 months follow-up
Bateman 1999 22 19 (7.4) 16 28.7 (7.4) 100.0 % -9.70 [ -14.47, -4.93 ]
Subtotal (95% CI) 22 16 100.0 % -9.70 [ -14.47, -4.93 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.99 (P = 0.000066)
5 >24 to 30 months follow-up
Bateman 1999 22 13.3 (6) 16 21.5 (8) 100.0 % -8.20 [ -12.85, -3.55 ]
Subtotal (95% CI) 22 16 100.0 % -8.20 [ -12.85, -3.55 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.45 (P = 0.00055)
6 >30 to 36 months follow-up
Bateman 1999 22 11.9 (3.3) 16 20.4 (10.5) 100.0 % -8.50 [ -13.83, -3.17 ]
Subtotal (95% CI) 22 16 100.0 % -8.50 [ -13.83, -3.17 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.13 (P = 0.0018)
Test for subgroup differences: Chi2 = 14.20, df = 5 (P = 0.01), I2 =65%
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Analysis 5.13. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 13 Mental state: 3a. Global severity - average score (SCL90-R,
high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 13 Mental state: 3a. Global severity - average score (SCL90-R, high = poor)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 within 6 months
Bateman 1999 19 2.4 (0.51) 19 2.4 (0.67) 100.0 % 0.0 [ -0.38, 0.38 ]
Subtotal (95% CI) 19 19 100.0 % 0.0 [ -0.38, 0.38 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
2 > 6 months to 12 months
Bateman 1999 19 2.2 (0.6) 19 2.4 (0.69) 100.0 % -0.20 [ -0.61, 0.21 ]
Subtotal (95% CI) 19 19 100.0 % -0.20 [ -0.61, 0.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.95 (P = 0.34)
3 >12 months to 18 months
Bateman 1999 19 2.1 (0.82) 19 2.4 (0.7) 100.0 % -0.30 [ -0.78, 0.18 ]
Subtotal (95% CI) 19 19 100.0 % -0.30 [ -0.78, 0.18 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.21 (P = 0.23)
4 >18 to 24 months follow-up
Bateman 1999 21 1.6 (0.7) 15 2.3 (0.6) 100.0 % -0.70 [ -1.13, -0.27 ]
Subtotal (95% CI) 21 15 100.0 % -0.70 [ -1.13, -0.27 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.22 (P = 0.0013)
Test for subgroup differences: Chi2 = 5.98, df = 3 (P = 0.11), I2 =50%
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Analysis 5.14. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 14 Mental state: 3b. Global severity - average score (SCL90-R,
high = poor, skewed data).
Mental state: 3b. Global severity - average score (SCL90-R, high = poor, skewed data)
>24 to 30 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
21 1.1 0.7 Overall partial hospitalisation group obtained significanly lower scores
than the control group (F=30.2, df=1,33, p<0.001). Significant group-
by-time interaction (Wilk’s lambda=0.59, F=7.3, df=3, 31, p<0.001).
Significant linear effect (F=19.4, df=1,33,p<0.001). Significantly dif-
ferent throughout follow-up period (p<0.001)
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Mental state: 3b. Global severity - average score (SCL90-R, high = poor, skewed data) (Continued)
Bateman 1999 General Psychiatric
Care
15 2.2 0.6
>30 to 36 months follow-up
Bateman 1999 Psychoanalyt-
ically Oriented Par-
tial Hospitalisation
21 0.8 0.6 Overall partial hospitalisation group obtained significanly lower scores
than the control group (F=30.2, df=1,33, p<0.001). Significant group-
by-time interaction (Wilk’s lambda=0.59, F=7.3, df=3, 31, p<0.001).
Significant linear effect (F=19.4, df=1,33,p<0.001). Significantly dif-
ferent throughout follow-up period (p<0.001)
Bateman 1999 General Psychiatric
Care
15 2.0 0.5
Analysis 5.15. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 15 Mental state: 4. Positive symptoms - average score (SCL90-R,
high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 15 Mental state: 4. Positive symptoms - average score (SCL90-R, high = poor)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 within 6 months
Bateman 1999 19 76.6 (8.5) 19 73.4 (14.7) 100.0 % 3.20 [ -4.44, 10.84 ]
Subtotal (95% CI) 19 19 100.0 % 3.20 [ -4.44, 10.84 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
2 > 6 months to 12 months
Bateman 1999 19 74.8 (12.2) 19 71.7 (17.9) 100.0 % 3.10 [ -6.64, 12.84 ]
Subtotal (95% CI) 19 19 100.0 % 3.10 [ -6.64, 12.84 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.62 (P = 0.53)
3 > 12 months to 18 months
Bateman 1999 19 70.7 (17.3) 19 73.1 (15) 100.0 % -2.40 [ -12.70, 7.90 ]
Subtotal (95% CI) 19 19 100.0 % -2.40 [ -12.70, 7.90 ]
Heterogeneity: not applicable
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(. . . Continued)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Test for overall effect: Z = 0.46 (P = 0.65)
4 >18 to 24 months follow-up
Bateman 1999 21 63.8 (16.6) 15 76.5 (12.4) 100.0 % -12.70 [ -22.18, -3.22 ]
Subtotal (95% CI) 21 15 100.0 % -12.70 [ -22.18, -3.22 ]
Heterogeneity: not applicable
Test for overall effect: Z = 2.63 (P = 0.0086)
5 >24 to 30 months follow-up
Bateman 1999 21 52.1 (19.6) 15 76.2 (10.9) 100.0 % -24.10 [ -34.13, -14.07 ]
Subtotal (95% CI) 21 15 100.0 % -24.10 [ -34.13, -14.07 ]
Heterogeneity: not applicable
Test for overall effect: Z = 4.71 (P < 0.00001)
6 >30 to 36 months follow-up
Bateman 1999 21 40.6 (19.6) 15 74.5 (9.6) 100.0 % -33.90 [ -43.59, -24.21 ]
Subtotal (95% CI) 21 15 100.0 % -33.90 [ -43.59, -24.21 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.86 (P < 0.00001)
Test for subgroup differences: Chi2 = 51.79, df = 5 (P = 0.00), I2 =90%
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Analysis 5.16. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 16 Quality of life: 1. Social adjustment - average score (SAS-SR,
high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 16 Quality of life: 1. Social adjustment - average score (SAS-SR, high = poor)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 > 12 months to 18 months
Bateman 1999 20 2.7 (0.6) 19 3.4 (0.6) 100.0 % -0.70 [ -1.08, -0.32 ]
Subtotal (95% CI) 20 19 100.0 % -0.70 [ -1.08, -0.32 ]
Heterogeneity: not applicable
Test for overall effect: Z = 3.64 (P = 0.00027)
2 >30 to 36 months follow-up
Bateman 1999 20 2.2 (0.5) 19 3.5 (0.7) 100.0 % -1.30 [ -1.68, -0.92 ]
Subtotal (95% CI) 20 19 100.0 % -1.30 [ -1.68, -0.92 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.64 (P < 0.00001)
Test for subgroup differences: Chi2 = 4.78, df = 1 (P = 0.03), I2 =79%
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Analysis 5.17. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 17 Quality of life: 2. Interpersonal problems - average score (IIP-
CV, high = poor).
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 17 Quality of life: 2. Interpersonal problems - average score (IIP-CV, high = poor)
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Mean Difference Weight Mean Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
1 > 12 months to 18 months
Bateman 1999 21 1.9 (0.3) 19 2.6 (0.3) 100.0 % -0.70 [ -0.89, -0.51 ]
Subtotal (95% CI) 21 19 100.0 % -0.70 [ -0.89, -0.51 ]
Heterogeneity: not applicable
Test for overall effect: Z = 7.37 (P < 0.00001)
2 >30 to 36 months follow-up
Bateman 1999 21 1.5 (0.4) 19 2.5 (0.5) 100.0 % -1.00 [ -1.28, -0.72 ]
Subtotal (95% CI) 21 19 100.0 % -1.00 [ -1.28, -0.72 ]
Heterogeneity: not applicable
Test for overall effect: Z = 6.94 (P < 0.00001)
Test for subgroup differences: Chi2 = 3.02, df = 1 (P = 0.08), I2 =67%
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Analysis 5.18. Comparison 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs
GENERAL PSYCHIATRIC CARE, Outcome 18 Leaving the study early.
Review: Psychological therapies for people with borderline personality disorder
Comparison: 5 PSYCHOANALYTICALLY ORIENTED PARTIAL HOSPITALIZATION vs GENERAL PSYCHIATRIC CARE
Outcome: 18 Leaving the study early
Study or subgroup PARTIAL HOSPITAL STANDARD CARE Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Bateman 1999 3/22 3/22 100.0 % 1.00 [ 0.23, 4.42 ]
Total (95% CI) 22 22 100.0 % 1.00 [ 0.23, 4.42 ]
Total events: 3 (PARTIAL HOSPITAL), 3 (STANDARD CARE)
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
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